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Resumo 
 
 
O sistema imunitário tem como ferramenta mais poderosa a produção de 
anticorpos, pois estes têm a capacidade de reconhecer e ligar-se a 
moléculas/organismos patogénicos. Atualmente, existem uma série de 
doenças que podem ser tratadas com anticorpos, nomeadamente com as 
imunoglobulinas G (IgG). Assim, o desenvolvimento de processos mais 
baratos e eficazes para a sua extração e purificação é uma área de interesse 
em biotecnologia. Os sistemas aquosos bifásicos (SAB) têm sido estudados 
para o efeito pois permitem a redução de custos e do número de passos 
envolvidos no processo, em comparação com os métodos convencionais. No 
entanto, os SAB tradicionais têm-se mostrado pouco seletivos, resultando em 
baixos fatores de purificação e rendimentos. Neste sentido, a incorporação de 
líquidos iónicos (LIs) nos SAB pode ser uma alternativa promissora para 
manipular a seletividade destes sistemas. Neste trabalho, estudaram-se SAB 
constituídos por polietileno glicol (PEG) de diferentes massas moleculares e 
um sal biodegradável (citrato de potássio), utilizando LIs como adjuvantes (5% 
m/m) para a extração de IgG de origem leporídea (coelho).  
Inicialmente, estudaram-se o tempo de extração, o efeito da variação da 
massa molecular do PEG em solução tampão de K3C6H5O7/C6H8O7 a pH≈7 e o 
efeito da variação de pH (5-9) sobre o rendimento (YIgG) e eficiência de 
extração (EEIgG%) de IgG. Os melhores resultados obtidos em termos de 
EEIgG% foram conseguidos com uma centrifugação a 1000 rpm durante 10 min 
para promover a separação de fases e equílibrio seguidos de 120 min de 
repouso. Este procedimento foi posteriormente aplicado aos restantes ensaios 
experimentais. Os resultados obtidos no estudo de PEGs de diferentes pesos 
moleculares revelaram uma elevada afinidade da IgG para a fase de PEG, 
principalmente com os PEGs de menor peso molecular (96% de EEIgG% com o 
PEG 400). Por outro lado, a variação de pH da solução tampão não mostrou 
um efeito significativo sobre a EEIgG%.  
Por fim, foi avaliada a influência da adição de vários LIs (5% m/m) na extração 
de IgG nos SABs compostos por PEG 400 a pH≈7. Nestes estudos foi possível 
obter uma EEIgG% de 100% com os LIs constituídos pelos aniões [TOS]
-
, 
[CH3CO2]
- 
e Cl
-
, apesar dos YIgG% obtidos serem inferiores a 40%. Por outro 
lado, com LIs constituídos pelos aniões Br
-
, assim como pelos catião 
[C10mim]
+
,
 
não se conseguiram obter valores de 100% para a EEIgG%, mas 
obtiveram-se melhores resultados em termos de YIgG%.  
Os SAB constituídos por PEG, um sal orgânico biodegradável e LIs como 
adjuvantes revelaram-se um método alternativo e promissor para a purificação 
de IgG. No entanto, são necessários ainda estudos adicionais de modo a 
reduzir a perda de IgG durante o processo. 
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Abstract 
 
The immune system is able to produce antibodies, which have the capacity to 
recognize and to bind to foreign molecules or pathogenic organisms. Currently, 
there are a diversity of diseases that can be treated with antibodies, like 
immunoglobulins G (IgG). Thereby, the development of cost-efficient processes 
for their extraction and purification is an area of main interest in biotechnology. 
Aqueous biphasic systems (ABS) have been investigated for this purpose, 
once they allow the reduction of costs and the number of steps involved in the 
process, when compared with conventional methods. Nevertheless, typical 
ABS have not showed to be selective, resulting in low purification factors and 
yields. In this context, the addition of ionic liquids (ILs) as adjuvants can be a 
viable and potential alternative to tailor the selectivity of these systems. In this 
work, ABS composed of polyethylene glycol (PEG) of different molecular 
weight, and a biodegradable salt (potassium citrate) using ILs as adjuvants (5 
wt%), were studied for the extraction and purification of IgG from a rabbit 
source. 
Initially, it was tested the extraction time, the effect on the molecular weight of 
PEG in a buffer solution of K3C6H5O7/C6H8O7 at pH≈7, and the effect of pH (5-
9) on the yield (YIgG) and extraction efficiency (EEIgG%) of IgG. The best results 
regarding EEIgG% were achieved with a centrifugation step at 1000 rpm, during 
10 min, in order to promote the separation of phases followed by 120 min of 
equilibrium. This procedure was then applied to the remaining experiments. 
The results obtained in the study of PEGs with different molecular weights, 
revealed a high affinity of IgG for the PEG-rich phase, and particularly for PEGs 
of lower molecular weight (EEIgG% of 96 % with PEG 400). On the other hand, 
the variation of pH in the buffer solution did not show a significant effect on the 
EEIgG%. 
Finally, it was evaluated the influence of the addition of different ILs (5% wt) on 
the IgG extraction in ABS composed of PEG 400 at pH≈7. In these studies, it 
was possible to obtain EEIgG% of 100% with the ILs composed of the anions 
[TOS]
-
, [CH3CO2]
-
and Cl
-
, although the obtained YIgG% were lower than 40%. 
On the other hand, the ILs composed of the anions Br
-
, as well as of the cation 
[C10mim]
+
, although not leading to EEIgG% of 100%, provide an increase in the 
YIgG%. 
ABS composed of PEG, a biodegradable organic salt and ILs as adjuvants, 
revealed to be an alternative and promising method to purify IgG. However, 
additional studies are still required in order to reduce the loss of IgG. 
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1.1. Scope and objectives 
Humans are affected by many diseases, like cancer, immunodeficiency, chronic auto-
immune diseases, infectious diseases, etc., for which an important alternative to their treatment 
could consist on the administration of monoclonal antibodies (mAbs) – passive immunotherapy. 
The US Food and Drug Administration (FDA) approved the first use of therapeutic mAbs in 1986, 
the Orthoclone OKT3 (1), that was produced in vivo by hybridoma cells (2). mAbs are used in high 
therapeutic doses, leading to an urgent increasing demand to obtain high quantities of pure 
mAbs. The production of therapeutic antibodies must met high standards of safety and efficiency, 
which translates into the requirement of high purity levels (3). This purity challenge constitutes 
the major drawback in the global biopharmaceuticals market (2). 
The high cost of the currently used downstream technologies is the key problem 
preventing the widespread use of mAbs in passive immunotherapy, and therefore there is the 
need to develop effective, economical, and rapid methods for mAbs purification (4). The typical 
approach used in the downstream processing of mAbs includes clarification, concentration, 
selective purification steps, and virus clearance (when produced by cells). Clarification, 
concentration and virus clearance contributes with about 10 % of the total downstream 
purification steps costs, which are between 20 and 60 %, and in some special cases, can go up to 
90 % of the total production costs (5,6). The purification is usually achieved by high-cost 
methodologies, such as chromatography, that are not viable in large-scale production. 
In order to suppress these and other shortcomings related with the traditional methods, 
such as chromatography, the extraction and purification using aqueous biphasic systems (ABS) 
constitutes an interesting alternative. ABS are more viable than traditional methods due to the 
fact that clarification, concentration and partial purification of the target protein can be combined 
in a single unit operation (2,7). The other great advantage is the fact that ABS are mostly 
composed of water and can be formed by combinations of polymers (such as polyethylene glycol, 
PEG) and organic salts (e.g., potassium citrate), avoiding thus the use of organic, volatile and 
hazardous solvents (8). However, these traditional polymer-salt systems present a restricted 
polarity range between the coexisting phases, which has been preventing high purity factors and 
yields to be achieved. To overcome this drawback, ionic liquids (ILs) can be used as phase-forming 
components of ABS. In fact, enhanced extractions, selectivities and recoveries have been achieved 
with IL-based ABS (9). The use of ILs in ABS leads to the possibility of controlling the phases’ 
polarities by an adequate choice of the constituting ions (8), and so, this high tunability makes 
them a desirable class of extraction solvents in liquid–liquid extraction processes. In addition, it 
Extraction and purification of IgG with ABS  
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was already shown that ILs can be used as adjuvants to tailor the selectivity and extraction 
aptitude for target biomolecules (10). Therefore, the aim of this work consists on the use of 
polymer-salt-based ABS, with the use of ILs as adjuvants, for the extraction and purification of 
immunoglobulins G (IgG) from a rabbit source. 
 
1.2. Antibodies 
Antibodies or immunoglobulins, known as Ig’s (11), are glycoproteins present in the 
plasma and extracellular fluids (humors) which constitute the humoral branch of the animal 
immune system (12–14). These active molecules are the first and the most important line of 
defense of the body immune system because they are produced by specialized B lymphocytes 
(white blood cells) in response to foreign and potentially toxic molecules or pathogens, known as 
antigens (6).  
B lymphocytes are responsible for the adaptive immunity, i.e., they are originated and 
matured in the bone marrow, and each expresses a unique antigen-binding receptor on its 
membrane where each antibody has a binding specificity for particular antigens (12). When these 
cells recognise and bind to an antigen, the cell divides itself rapidly, differentiating into memory B 
cells and effector B cells, called plasma cells (14). Furthermore, this immunological response is 
heterogeneous resulting in many different cell lines of B lymphocytes producing antibodies to the 
same antigen (15).  
 
1.2.1. Antibody structure and function 
Antibodies have a common structure with four polypeptides (Figure 1) found in many 
proteins, regardless of their specificity (13,16). These four polypeptides, with an Y-shape, consist 
of two identical heavy chains (H) with a molecular weight of 50 kDa or more; and two identical 
light chains (L) with a molecular weight of 25 kDa each, resulting in a total molecular weight 
(immunoglobulin) of approximately 150 kDa (13,15,16). Furthemore, each heavy and light chain 
are held together by a combination of non-covalent interactions to form a heterodimer (H-L) 
(14,15). All four polypeptide chains contain variable (V) and constant (C) regions found at the 
amino and carboxyl terminal portions, respectively (13). 
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Figure 1: Schematic representation of the structure of an antibody: it contains an amino-terminal variable 
region (aqua and tan, respectively), and the constant regions (purple and red) (with limited variation that 
defines the two light-chain subtypes and the five heavy-chain subclasses). Some heavy chains (γ, δ, and α) 
also contain a proline-rich hinge region (black) (14). 
 
The constant region exhibits limited variation that defines the two light-chain subtypes and 
the five heavy-chain subclasses (α, µ, δ, ε, γ). Each of these five different heavy chains is called an 
isotype and these determine the class of antibody produced by the B cells (Figure 2): IgM(µ), 
IgG(γ), IgA(α), IgD(δ), or IgE(ε) (Table 1). These classes determine the type and the temporal 
nature of the immune response (13,14,16), as well as the effector functions (11). 
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Table 1: Chain composition of the five immunoglobulin classes in humans (14). 
Class Heavy chain Subclasses Light chain Formula 
IgG γ γ1, γ2, γ3, γ4 κ or λ γ2κ2 
γ2λ2 
IgM μ None κ or λ (μ2κ2)n 
(μ2λ2)n 
n = 1 or 5 
IgA α α1, α2 κ or λ (α2κ2)n 
(α2λ2)n 
n = 1, 2, 3 or 4 
IgE ϵ None κ or λ ϵ2κ2 
ϵ2λ2 
IgD δ None κ or λ δ2κ2 
δ2λ2 
 
The hypervariable regions, called complementarity-determining regions (CDRs), are 
dependent and determine the antibody specificity (11). These regions are located between the 
amino-terminal of light and heavy regions, with a molecular weight of 50 kDa, and these 
segments are the first 110 amino-acids of the chain. Moreover, these regions correspond to the 
region where the amino-terminal groups join to form two identical antigen binding-sites (Figure 3) 
(binding to the epitope), called Fab (“fragment of antigen-binding”) (14,16). Each Fab fragment 
can bind to an antigen, and as two Fab fragments are present in the antibody, each antibody 
molecule is at least bivalent (16). Furthemore, there are also the carboxy terminal regions of the 
two heavy chains (tail) fold together in order to create the Fc domains or crystallizable fractions, 
and these have a molecular weight of 50 kDa and no antigen binding activity. The Fc is also 
responsible for the Ig biological functions, like natural killer cell activation, classical complement 
pathway activation and phagocytosis (14,16). These two arms (Fab) and the tail (Fc) are linked by 
a region rich in proline, threonine and serine, called the hinge, that provides the ability of the 
antibody to interact with a variety of antigens, due to its lateral and rotational movement (16). 
General introduction 
 
7 
 
 
Figure 2: Development of B-cells, in which mature B cells are activated and differentiated in presence 
of an antigen. mIgM and mIgD are membrane-associated Ig’s; IgG, IgA, and IgE are secreted 
immunoglobulins (14). 
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Figure 3: Amino-terminal portions corresponding to the variable regions of the antibody that bind to an 
antigen (16). 
 
The antibodies importance is mostly related with their function and/or binding specificity for 
specific antigens (16). Neverthless, antibodies have three functions: the binding versatility, the 
binding specificity, and the biological activity (11). In response to a particular antigen, antibodies 
produced by a single B cell clone is termed a monoclonal antibody; if they are produced by a 
mixture of various B lymphocyte clones they are termed polyclonal antibodies (12). In this work, 
polyclonal antibodies from rabbit serum were investigated. 
 
1.2.2. Polyclonal and monoclonal antibodies 
The monoclonal antibodies (mAbs) are antibodies of a single idiotype secreted by one clone 
of B lymphocytes, i.e., a single hybridoma reacts with the same epitope on antigens (11,12,16). 
The somatic cells hybridization was described for the first time by Georges J. F. Köhler and César 
Milstein in 1975 (17). On the other hand, polyclonal antibodies (pAbs) are heterogeneous, since 
they represent a collection of antibodies secreted by different B cell lineages, allowing them to 
recognize multiple epitopes of the same antigen (16). pAbs are acquired from serum and 
comprise heterogeneous and more complex mixtures of antibodies of different affinities. On the 
other hand, mAbs are produced in vitro, using for instance Chinese hamster ovary (CHO) cells (18). 
The pAbs and mAbs have their advantages and disadvantages in terms of generation, cost, 
and overall applications (19). Both play an important role, with several applications in biology, 
biomedical research, diagnosis and therapy (3,12). mAbs have some disadvantages in relation to 
pAbs, such as a higher susceptibility to small changes in pH and salt concentration (16). 
Furthermore, the production of mAbs is time-consuming, since from the immunization until the 
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establishment of a cloned cell line it can take from 3 to 6 months (19). The production of pAbs can 
be less time-consuming and less expensive. However, the immunization and response of the 
mammal cannot be discarded.  
The mAbs also have effector functions, and thus they cannot produce the desired biologic 
response, such as a readily activation of the complement, and precipitation or agglutination of 
antigens (11). mAbs also display monospecificity that limits their usefulness since small changes in 
the structure of an epitope can markedly affect their function. Therefore, mAbs are less tolerant 
to minor changes in the antigen (polymorphism, heterogeneity of glycosylation, or slight 
denaturation) (16). However, the attractive specificity of mAbs is an extremely important feature 
in a great array of clinical laboratory diagnostic tests, such as in detecting and identifying serum 
analytes, cell markers, and pathogenic agents, among others (19). Moreover, mAbs have also 
other advantages as their homogeneity, which it is useful in evaluating changes in molecular 
conformation and protein-protein interactions (16). Moreover, a continuous culture of a single 
clone of B cell hybridomas offers a reproducible supply of antibodies (19). On the other hand, 
pAbs offer additional vantages compared with mAbs, such as the capability to recognize multiple 
epitopes and their tolerance to minor changes in the antigen (e.g., polymorphism, heterogeneity 
of glycosylation or slight denaturation). 
Nowadays, mAbs are used in the treatment of several diseases and have an enormous utility 
in diagnosis and immunologic investigations (14,19,20). The mAbs market is under a fastest 
growing and is amongst the most lucrative in the biopharmaceuticals industry (21). More than 26 
monoclonal antibody-based therapeutics were already approved by the FDA (6,20,21), and 
according to a recent report from The Antibody Society (2013/2/28), 36 other therapeutic mAbs 
are in clinical trials (13). Thus, mAbs constitute the largest product segment in the 
biopharmaceuticals market with an estimated share of 25.6% in 2013, and accounting with 
US$51.1 billion (2,21). 
Within the wide range of therapeutic mAbs and pAbs, one particular type of antibodies, 
namely IgG, are amongst the most potent effector molecules of the humoral immunity and play 
an essential role in the recognition of foreign proteins. Hence, they are increasingly being used as 
alternative drugs to treat many diseases (22).  
 
1.3. IgG structure and molecular characteristics  
IgG is the main class of antibodies present in the blood, lymph, peritoneal, and cerebro-spinal 
fluids (23), and constitute about 20 % of the total plasma proteins, with a total concentration in 
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blood within 10–25 mg/mL (22,24). The basic unit of all IgGs (Figure 4) consists of four 
polypeptide chains, comprising two identical light chains (either κ or λ) and two identical heavy 
chains (γ) (11,24). These chains are held together by non-covalent and covalent bindings 
(interchain disulfide bridges), and their sctruture resembles the letter Y with a well-defined 
globular structure (24). 
 
Figure 4: IgG structure: light chains (shades of red), disulfide bonds (thick black lines), heavy chains (blue 
and purple) (14). 
In 1960, four subclasses of IgG in human blood were identified: IgG1, IgG2, IgG3 and IgG4 (in 
a decreasing order of abundance) (Figure 5) (25). Although all subclasses share a common genetic 
basis and have the same size and conformation, they differ in the specific sequence of amino 
acids in the variable domains (i.e., the antigen-binding domains, Fab) (11,22,24).  
 
Figure 5: General structure of the subclasses of human IgG (IgG1, IgG2, IgG3, and IgG4). The main difference 
is related with the number and arrangement of the interchain disulfide bonds (thick black lines) that link the 
heavy chains. Human IgG3 has 11 interchain disulfide bonds (14). 
 
All subclasses of IgG exist in different species and their biochemical composition offers the 
basis for their biological functions. IgGs are smaller than the other Ig’s classes, and during their 
isolation and purification processes, they shown to be more stable than other classes of Ig’s, since 
they do not aggregate and they do not require the use of sugar stabilizers at pH values between 
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4.0 and 4.5 (26,27). Furthemore, the rate of synthesis of IgG is higher than in other Ig’s classes, 
and IgG is also highly soluble at physiological conditions (22,26). IgG also displays a half-life longer 
than others Ig’s. (28). In Table 2, a summary of the main properties and characteristics of human 
IgG is provided. 
 
Table 2: Main properties of human IgG (29). 
Properties 
Immunoglobulin isotype 
IgG1 IgG2 IgG3 IgG4 
Heavy chain γ1 γ2 γ3 γ4 
Light chain κ, λ κ, λ κ, λ κ, λ 
Other chains - - - - 
Molecular weight (kDa) 146 146 170 146 
Average concentration in serum (mg
.
mL
-1
) 9.0 3.0 1.0 0.5 
Half-life period (days) 21 20 7 21 
Total serum immunoglobulins (%) 50 17 5 3 
Carbohydrates content (%) 2 – 3 2 - 3 2 – 3 2 – 3 
 
1.3.1. Advantages and applications of IgG 
Currently, the IgG isotype is one of antibodies most used in a variety of scientific, medical 
approaches and therapeutic applications (30). These applications are a result of the higher degree 
of affinity and specificity of IgG for a target antigen in comparison to other antibodies (16). Thus, a 
profound improvement on the human health can occurs by their use in diagnostic assays and 
therapeutics (16). One of the aplications for this antibody consists on the intravenous IgG (IVIG) 
therapy. This therapeutic application can be applied to patients with autoimmune and 
inflammatory diseases (e.g., Myesthenia gravis, Crohn’s disease, Multiple sclerosis), as well as in 
patients with asthma, cardiovascular and infectious diseases (6,31). Other important application 
of IgG is in oncology (2). In this situation, the immunoglobulins act as carrier agents of toxins or 
radiolabeled isotopes to the cancerous cells (30). In addition, these antibodies are suitable for use 
in indirect flow cytometry assays, for ELISA or cytotoxicity studies (32). 
 
1.3.2. Sources of IgG 
Vertebrates produce five isotypes of immunoglobulins classified as IgG, IgA, IgM, IgD, and IgE 
(33). In mammals, there are five IgG subclasses (1 to 5), which differ in effector functions (28), 
since different IgG subclasses may be differentially produced in response to different pathogens 
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(34). Thus, the choice of the mammal for producing IgG is relevant because the quantity of 
antibody harvested depends on the animal size and robustness of their immune response (16). 
Most polyclonal antibodies are obtained from the serum of goats or rabbits. mAbs are typically 
generated from rat or mouse monoclonals, yet rabbit and goat can also be used (18). 
In humans, as previously mentioned, there are four subisotypes of γ heavy chains 
corresponding to the subclasses (isotypes) IgG 1, 2, 3 and 4 (14). Bovines have two subclasses of 
IgG, namely IgG1 and IgG2, and their concentrations in plasma are approximately the same as in 
humans (Table 3) (33). They play a plurality of immune functions, such as the detection and 
elimination of invading microorganisms, for example bacteria and viruses (33), and thus bovine 
IgG is widely used as an immunological supplement food, especially in infant formulations (33). 
Finally, rabbits, sheep, and goats are the most commonly used mammals for producing IgG (16). 
Among them, rabbits are the most used to generate antibodies for research because they are 
cheaper (16), provide a large volume of immune sera (35), and are highly immunogenic in 
responding to various immunization regimens (34). Furthemore, in comparison to other species 
(e.g., human, mouse, rat), the rabbit immune system is seemingly unique since it possesses only 
one IgG subclass (28,34). The content of IgG in serum rabbit ranges between 13.6 mg.L-1, with a 
molecular weight of 143.9 kDa (heavy chains of 55 kDa and light chains between 31 and 21.5 kDa) 
(34). Rabbit IgG antibodies are stable at high temperatures (at 70°C for 10 min are able to keep 
the activity without any loss) (36). One important research application involving rabbit mAbs was 
on the HIV vaccine development, since these mAbs are able to generate long CDR3 regions, 
important for neutralizing the human immunodeficiency virus type 1 (HIV-1) (34). A summary 
describing the main features amongst the Abs from different sources is described in Table 3. 
 
Table 3: Some features that characterize Bovine, Human and Rabbit IgG, adapted from (6,24,33,34,37). 
Source 
Class and 
sub-classes 
Concentration of 
IgG in serum /(mg
.
mL
-1
) 
pI 
Human 
IgG 10–25 
(blood) 
6.6 
IgG 1 5–12 8.6 
IgG 2 2–6 7.4 
IgG 3 0.5–0.1 8.3 
IgG 4 0.2–1 7.2 
Bovine 
IgG 40 (blood) 5.65 
IgG 1 11.2 5.6 
IgG 2 9.2 5.0 
Rabbit IgG 13.6 7.8 
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1.4. Methods for the purification of antibodies 
In the past years, advances in science have led to a new era of therapeutic-based drugs – 
biopharmaceuticals (38). Thus, the demand for purified proteins, such as specific antibodies, has 
increased considerably not only for medical use but also for advanced diagnosis (5). The typical 
steps in antibodies (mAbs and pAbs) recovery and processing are: (i) harvest, (ii) clarification by 
the removal of cells and cell debris by centrifugation or microfiltration, (iii) concentration by 
ultrafiltration, (iv) selective purification steps, (v) virus inactivation and clearance, and (vi) 
validation and quality control tests (6) (Figure 6). 
 
Figure 6: Typical steps involved in the production of mAbs and pAbs. 
 
The antibodies purification (iv) is usually performed by a series of chromatographic 
operations, comprising the capturing, an intermediate purification (isolation), and polishing (39) 
(Figure 7).  
 
 
Figure 7: The steps and methods involved in the purification stage of the downstream processing of 
antibodies (adapted from (26)). 
 
 i) 
 i) 
 i) 
 i) 
 i) 
i) ii) iii) iv) v) vi)
Purification 
 
 
 
 
a) Concentration 
Precipitation 
Filtration  
Adsorption 
 
 
 
 
b) Isolation 
Affinity chromatography; 
c) Polishing 
Size-exclusion chromatography (SEC); 
Reverse-phase chromatography; 
Ion-exchange chromatography (IEC); 
Hidrophobic interaction chromatography (HIC).  
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Regarding the steps of purification, the first step consists on the concentration, where the 
sample can be concentrated using membranes or precipitation agents, such as ammonium 
sulfate, polyethylene glycol or caprylic acid (26); in the case of pAbs, this step consists on a 
precipitation induced by ethanol (40). This last method consists in a separation stage by the 
conversion of soluble proteins to an insoluble state (13) that can be recovered by centrifugation 
and filtration (32). The second step of purification includes the isolation by affinity 
chromatography using immobilized ligands (26,41). Each type of protein has unique properties, 
making them specific for different target ligands (15). Affinity purification procedures involve the 
interaction of an antibody with its antigen, generally by using binding buffers, at physiological pH 
and ionic strength. The antibody-ligand binding can be significantly affected by the concentration 
of salt in the buffer and through the impact of the ionic and dispersive interactions involved (26). 
Biological affinity interactions are mediated by complex combinations regarding their shape, 
charge, hydrophobic, van der Waals and/or hydrogen bonding interactions. The highest 
association constant can be achieved through the identification of the type of interaction, thus 
selecting the buffer conditions (26,42). Proteins A, G and L are the most used for the isolation of 
different Ig’s from various mammalian species. However, the proteins and IgG interactions (Table 
4) are not of the same type and strength for all animal IgGs and IgG subclasses (14,32,42).  
After the interaction and immobilization of the antibody by the immobilized ligand, the final 
step consists on the polishing attained by size exclusion chromatography (SEC). This method 
consists in the separation of proteins according to their size at isocratic mode. The principal trait 
of this technique is its non-adsorptive interaction with the sample, and even with a high retention 
time, there is no damage or inactivation of the proteins (43). Thereby, this technique represents 
an important tool to remove aggregates within the antibodies purification. Nevertheless, it is not 
viable for large-scale applications (6,25,44).  
 
Table 4: Binding affinity for proteins A, G, and L with a variety of immunoglobulin species. w = weak 
binding, m = medium binding, s = strong binding, nb = no binding, – Unknown. 
IgG source Subclasses Protein A Protein G Protein L 
Human 
IgG1 s S s 
IgG2 s S - 
IgG3 - S - 
IgG4 s S - 
Rabbit IgG s S w 
Bovine IgG w S nb 
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As explained above, the methods used for the purification of IgG involve several steps, which 
make the process costly and time-consuming (38,44,45). Furthermore, the application of 
chromatographic techniques in downstream processing is limited due to their high costs, batch 
operation, throughput and complexity to scale up (46). Thus, other alternatives for the separation 
and purification of proteins, particularly for therapeutic applications, have been developed with 
the aim of reducing costs and to be easily scaled-up, such as adsorption, ultrafiltration (47), 
reverse micelle-mediated approaches (48), and liquid-liquid extractions by means of aqueous 
biphasic systems (ABS) (38).  
 
1.4.1. Extraction of proteins using aqueous biphasic systems (ABS) 
1.4.1.1. General concepts 
Liquid-liquid extraction processes with ABS represent a viable alternative for the 
purification of biopharmaceuticals. An ABS consists on two immiscible aqueous-rich phases based 
on polymer/polymer, polymer/salt or salt/salt combinations (7,21,45,49). The formation of ABS 
was firstly observed by Beijerinck in 1896 (50). However, only in the 50s, Albertsson 
demonstrated their use for the isolation and separation of plant organelles and viruses (51). In the 
past years, ABS have shown to be an alternative, efﬁcient, and clean approach for the separation 
and puriﬁcation of a broad array of (bio)molecules (7,45,49). On the whole, both phases are 
composed of approximately 70-90 wt % of water, which means a biocompatible medium for 
biologically active molecules, constituting therefore an important advantage when the goal is to 
extract proteins and/or enzymes (52).  
The choice of the phase-forming components of ABS and their concentrations should be 
made taking into account the substances that need be purified and the operational requests. Salt-
polymer ABS are highly recommended because these systems tend to be less viscous than 
polymer-polymer ABS, facilitating therefore the separation of the phases (53). This type of 
systems has been widely exploited for the primary recovery of biological products, such as 
enzymes (54), antibiotics (55,56), antibodies (6), among others (57). Another advantage of these 
systems is the fact that the adition of salt leads to an optimization of the partitioning of the 
solute, typically used in the isolation and purification of biomolecules (13). The basis of separation 
of (bio)molecules in ABS is a direct result of their selective distribution between the two distinct 
aqueous phases (58). However, a high extractive performance can be achieved by the 
manipulation of the affinity of the target compound for each of the aqueous-rich phases. Even so, 
traditional polymer-salt and salt-salt systems display a restricted polarity at the coexisting phases 
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which have limited their successful application to the purification (selective extraction) of target 
and added-value products, such as biopharmaceuticals (3,59). To overcome this drawback, ILs 
have been introduced as phase-forming components of ABS leading to a high extraction 
performance (9), and as will be discussed below in more detail. 
For the design of ABS as extraction and purification processes, their phase diagrams and 
respective tie-lines are required. All ABS have a unique phase diagram under a particular set of 
conditions, such as temperature and pH (52,57). Thus, before any application, it is extremely 
important to determine the respective phase diagram for a particular pair of phase-forming 
components aiming at gathering the information necessary on the monophasic/biphasic regimes 
before any extraction/purification procedure. In addition, the determination of the corresponding 
tie-lines (TLs) gives the equilibrium composition of the top and bottom phases (60–62). Figure 8 
depicts an example of a phase digram of an ABS composed of a polymer (polyethylene glycol, 
PEG), a salt and water, and the binodal curve. The binodal curve, TCB, represents the separation 
between the miscible and immiscible regions, i.e., above the binodal curve it is located the 
biphasic region, while below it is the single phase region (60,62). The larger the biphasic region, 
the higher the ability of the phase-forming components to undergo liquid-liquid demixing. Three 
mixture compositions at the biphasic region are also identified as X, Y and Z in Figure 8. The 
mixtures X, Y and Z are along the same tie-line (TL) meaning that all the initial mixtures will 
present the same top (TPEG, TSalt) and bottom phase compositions (BPEG, BSalt) (63). 
The TLL is a numerical indicator of the composition difference between the two phases and is 
often used to correlate with the trends observed in the partitioning of solutes between the 
phases (3). 
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Figure 8: Schematic representation of a phase diagram of an ABS. TCB - Binodal curve, C - Critical point, TB - 
Tie-line, T - composition of the top phase, B - composition of the bottom phase; and X, Y and Z - total 
composition of biphasic mixtures (62). 
 
1.4.1.2. ABS as an alternative to conventional methods 
 Conventional biotechnological processes usually require numerous steps with high energy 
and chemical consumptions, representing about 60-90% of the cost of the final product (5). ABS, 
due to their advantages, are a potential alternative to the traditional technologies for the 
recovery and purification of biomolecules (5). 
 The pratical strategies for the design of an appropriate recovery process using ABS can be 
divided into four stages, namely the initial physicochemical characterization of the feedstock – 
product and major contaminants molecular weight, isoelectric point, hydrophobic character, etc; 
selection of the type of ABS; selection of the system parameters; and evaluation of the influence 
of the process parameters upon the product recovery/purity (57) (Figure 9). 
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Figure 9: Simplified representation of the strategies for the design of the recovery of biological products 
using ABS (adapted from (57)). 
 
ABS are favourable for the extraction of proteins due to the high amount of water present in 
the phases (2,5,7). Moreover, these systems are of lower cost when compared with 
chromatographic strategies, are more environmentatlly benign since the use of volatile organic 
compounds is avoided, allow the scale-up and lead to high extraction performance and purity 
levels. For instance, a comparison between a purification process using ion-exchange 
chromatography, with a previous acetone fractionation, and an ABS extraction, demonstrated 
superior overall recovery of the enzyme α-galactosidase in ABS (11.5 vs. 87.6%, respectively) (64). 
Other widely used technique for the purification of proteins/enzymes consists on the 
precipitation of the target molecule with ammonium sulfate. A comparison between the two 
methods was already performed and ABS exceeded the precipitation method, achieving a greater 
recovery yield (88 % vs. 49 %) and purity (100 % vs. 89 %) of papain from wet Carica papaya latex 
(65). It is thus clear that ABS can serve as an alternative method over other conventional 
separation processes, and in particular for proteins and enzymes, and so, these systems have 
been subject of an increased attention and research. 
 
1.4.1.3. Extraction and purification of IgG using ABS 
The first report describing the use of polymer/salt ABS for the purification of both 
monoclonal and polyclonal antibodies from different feedstocks dates from 1992, by Sulk et al. 
Initial 
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of the feedstock 
•  Product and major contaminants 
molecular weight; 
• Isoelectric point; 
• Hydrophobic character. 
Selection of the 
type of ABS 
• Polymer – salt; 
• Polymer – polymer; 
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• Phase-foming 
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• Sample loading; 
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(66) using PEG/phosphate-based salts systems. Later on, Zijlstra and co-workers (67) synthesized a 
functionalised PEG to combine with dextran and to form ABS, aiming at recovering IgG from 
hybridoma cells. Moreover Asenjo et al. (68) used an ABS composed of PEG, a phosphate-based 
salt and NaCl to successfully recover IgG from hybridoma cell supernatants in the top phase. In 
the same line, Rito-Palomares et al. (69) studied PEG-potassium phosphate ABS to process whole 
bovine blood, resulting in the partition of bovine serum albumin (BSA), haemoglobin and IgG into 
the PEG-rich phase and cell debris into the phosphate-rich bottom phase. A partition coefficient 
for IgG of 55 was attained (69). Finally, Aires-Barros and co-workers (2–4,6,7,20,21,44,49,70,71) 
devoted a large attention on the study of ABS for the purification of IgG. A list of the systems, 
phase-forming components and conditions investigated are summarized in Table 5. It should be 
highlighted that all these investigations were carried out with CHO and hybridoma cell 
supernatants, and thus with monoclonal IgG.  
 
Table 5: List of different ABS used to purify and recover monoclonal IgG. 
ABS % (w/w) pH Recovery yield (%) Ref. 
[PEG 3350 +  Potassium Phosphate] + NaCl 6 89 (71) 
[PEG 3350 + Potassium Phosphate] + NaCl 6 97 (6) 
[PEG 6000 + Potassium Phosphate] + NaCl 6 88 (3) 
[PEG 3350 + Potassium Phosphate] + NaCl 6 80 (4) 
[PEG 3350 + Sodium Citrate] 6 97 (70) 
[PEG 3350 + Sodium Citrate ] + NaCl 6 99 (21) 
[PEG 3350 + Dextran 500 kDa] + Diglutaric acid 7 97 (49) 
[PEG 3350 + Dextran 500 kDa] 7 95 (20) 
[PEG 6000 + Dextran 500 kDa] + NaCl 3 87 (2) 
 
In some studies (3,4,6,71), several ABS for the extraction and purification of IgG from a 
mixture of proteins or Chinese hamster ovary (CHO) cells supernatant were investigated. The 
authors observed that the NaCl and the phosphate-based salt concentrations are the factors that 
display the most significant influence on the amount of native IgG present at the top phase (3). 
When the PEG concentration is increased, a decrease on the partition coefficient and extraction 
yield of IgG for the top phase was observerd (3,6). Considering a two-step extraction an IgG total 
yield of 76% and a purity of 100% were obtained (6). Therefore, the authors proposed a multi-
stage equilibrium aqueous two-phase extraction for the successful purification of human 
antibodies from a CHO cells supernatant (4,6,71). 
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The viability of using multi-stage extractions, as an important tool for the removal of 
contaminants in the downstream processing of human antibodies, was also shown by Rosa et al. 
(20) with polymer-polymer ABS. In an adiditonal study (70), the authors demonstrated the 
feasibility of combining the extraction carried out by ABS with HIC (Hydrophobic interaction 
chromatography) and SEC (Size exclusion chromatography) for the purification of human 
therapeutic antibodies without the use of any conditioning step  in the three unit operations. ABS 
composed of 10% (w/w) of PEG 3350 and 12% (w/w) of sodium citrate, followed by a phenyl-
sepharose HIC column and SEC led to the acquisition of 100% pure IgG with a 90% yield. 
The partitioning and purification of antibodies was also enhanced using functionalised-PEG 
polymers as phase-forming components of ABS (49). An ABS composed of 5% dextran, 8% of PEG 
diglutaric acid and 10 mM phosphate buffer at pH 7, allowed the extraction of 97% of IgG to the 
top phase, with a purity of 94% (49). In 2007, Hye-Mee Park et al. (72) suggested a novel affinity 
separation method, where horseradish peroxidase (HRP) and human IgG were used as a ligand 
carrier and an affinity ligand, respectively. They tested two different ABS, one consisting of 
potassium phosphate (15%, w/w) and PEG 1450 (10%, w/w) and the other composed of dextran 
500 kDa (5% w/w) and PEG 8000 (5% w/w). The authors (72) observed that conjugated human 
IgG-HRP preferentially migrates for the PEG-rich top phase, whereas human IgG, rabbit anti-
human IgG and goat anti-mouse IgG preferred the salt or dextran-rich bottom phase. The best 
results were obtained with the dextran-based ABS where the yield and purity of the recovered 
rabbit anti-human IgG were 90.8 and 87.7%, respectively (72).  
Vargas and co-workers (73) developed a new and cost-effective plasma fractionation method 
using an ABS composed of PEG 3350, potassium phosphate and sodium chloride, at pH 6.1, for IgG 
from human plasma collected from Costa Rican healthy donors. At the best conditions evaluated, 
IgG precipitated in the PEG-rich upper phase (83% recovery), and after polishing, IgG was 
obtained at a recovery of 70% and with a purity of 92% (73). Wu et al. (74) used PEG 4000, 
hydroxypropyl starch (HPS) and NaCl at pH 8.0 to extract IgG from human serum albumin. The 
results obtained displayed a IgG recovery in the PEG-rich phase with 99.2% of extraction yield 
(74). 
Polymer-polymer ABS have been largely investigated for the purification of IgG 
(2,7,20,44,49,74–76). However, these systems display high viscosities at the coexisting phases 
(38). Furthermore, dextran is too expensive as a phase-forming component to scale-up the 
extraction process (77). To overcome these drawbacks, most works in literature describe the use 
of polymer–salt systems (3,4,6,21,69–73,78,79) thereby decreasing the viscosity of the coexisting 
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phases, providing a higher density difference, and thus faster separation rates, as well as by 
providing lower cost systems and their scale-up (38,80). These systems are mainly composed of 
inorganic salts, especially phosphate-based (21,38), and some biodegradable organic salts, such as 
sodium citrate (8,80). 
One of the most used polymers in ABS is PEG (Figure 10). PEG is a polyether diol with two 
terminal hydroxyl groups, which can be exposed to chemical derivatization. Polymers offer some 
degree of design, for instance, by varying the length of the polymeric chains, i.e., by changing 
their average molecular weight, or by changing the structure of the monomer unit. PEG also 
displays some attractive properties, such as biodegradability, low toxicity, low volatility, low 
melting points, high water solubility and low cost (9). However, the hydrophilic nature of PEG 
limits the applicability of this technique when the goal is to extract hydrophobic biomolecules. To 
overcome this limitation, recent works have introduced ionic liquids (ILs) to tune the properties of 
PEG through the modification of its chemical structure and thus increasing the extraction yield (9), 
as well as by using ILs as adjuvants in traditional polymer-salt or polymer-polymer ABS (9,81–84).  
 
 
Figure 10: Chemical structure of PEG with the molecular formula H-(O-CH2-CH2)n-OH.  
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1.5. Ionic liquids as novel and alternative strategies in polymer-salt-based ABS 
Ionic liquids (ILs) are organic salts with melting points below 100 °C (85). They are usually 
constituted by a large and organic cation and an organic or inorganic anion (22). The low melting 
temperatures of ILs are typically associated with the lack of an ordered crystalline structure (22). 
Amongst the large range of ILs that can be synthesized, the most commonly studied are nitrogen-
based, with their general cation structures presented in Figure 11 (86–89). 
 
Figure 11: Cation structures of nitrogen-based ILs: (i) dialkylimidazolium, (ii) dialkylpyrrolidinium, (iii) 
dialkylpiperidinium, (iv) alkylpyridinium and (v) tetralkylammonium. 
 
The first IL synthesized was ethylammonium nitrate, in 1914, by Paul Walden (26). Later, in 
1934, Charles Graenacher filled the first patent regarding an industrial application of ILs in the 
preparation of cellulose solutions (27). During the 2nd World War, new patents involving the use 
of ILs have appeared, while contemplating mixtures of aluminium chloride (III) and 1-
ethylpyridinium bromide for the electrodeposition of aluminium (28,29). Despite these findings, 
only more recently, in 1992, air and water stable ILs were synthetized (30). 
ILs are a group of “green solvents” with attractive properties, namely a negligible volatility 
and non-flammability, under ambient conditions, which contributed to this characterization 
(63,90–92). Other important properties include a high chemical/thermal stability, a wide 
electrochemical window, a strong solubility power and a large number of possible variations in 
the cation and anion which further allow the fine-tuning of these properties (63,90,91). 
Many researchers have reported the capacity of enzymes and proteins to remain stable and 
active in presence of IL aqueous solutions (91,93). The first attempt on the direct extraction of 
proteins using ABS composed of ILs was reported by Wang et al. (94) using and ABS formed by the 
hydrophilic IL 1-butyl-3-methylimidazolium chloride ([C4mim]Cl) and K2HPO4. No chemical 
(bonding) interactions between proteins and the IL ions were observed during the extraction 
process, as well as no alterations on the native conformation of proteins. In the same line, other 
recent works demonstrated the extraction performance and the stability of proteins using IL-
based ABS (93,95–97). 
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Cheng et al. (98,99) evaluated a large series of hydrophobic ILs for the extraction of heme-
proteins, namely hemoglobin and cytochrome-c. Regarding the extraction of antibodies with IL-
based systems, two works were found in the literature. Martínez-Aragón et al. (5) tried to purify 
IgG monoclonal antibodies from their fermentation broth with three ILs immiscible with water, 
namely tetradecyl(trihexyl)phosphonium bistriflamide, [P14,6,6,6][NTf2], tetradecyl(trihexyl) 
phosphonium dicyanamide, [P14,6,6,6][N(CN)2], and 1-ethyl-3-methylimidazolium 
bis[(trisfluoromethyl)sulfonyl] amide, [C2mim][NTf2]. They concluded that IgG does not suffers 
precipitation with [P14,6,6,6][N(CN2)], [P14,6,6,6][NTf2] and [C2mim][NTf2] (5). The stability of IgG1 was 
also tested into two ILs, namely Iolilyte 221 PG (an ammonium-based IL with an 
oligopropyleneglycol unit at the side chain) and tributylmethylphosphonium methylsulfate 
([P4,4,4,1][CH3SO4]). At 10% w/w of ILs, the authors did not observe the IgG fragmentation or 
agregation; however, IgG1 formed aggregates at higher concentrations of Iolilyte 221 PG (100). 
 
1.5.1. ILs as adjuvants in polymer-salt- based ABS  
Besides the introduction of ILs to functionalize PEG (101), in others works, small quantities of 
ILs (as adjuvants) were added into conventional polymer-salt-ABS to tailor the extraction and 
selectivity performances (9,81–84). As already mentioned, the hydrophilic nature of PEG limits the 
applicability of the ABS technique, specially, when the goal is to extract hydrophobic 
(bio)molecules (9,81,83,84,102), like IgG. For example, Pereira et al. (9) investigated the potential 
of using ILs as adjuvants (at 5 wt%) in typical PEG/inorganic salt ABS for the separation and 
purification of model biomolecules (L-tryptophan was used as an essential amino acid model). In 
general, the results showed that salting-in inducing ILs enhance the partition coefficient of L-
tryptophan for the PEG-rich phase while salting-out inducing ILs decrease the partitioning of the 
amino acid. In the same line, Hamzehzadeh et al. (84) investigated the potential of the IL 1-butyl-
3-methylimidazolium bromide ([C4mim]Br) as an adjuvant in ABS formed by PEG 400 + tri-
potassium citrate (K3C6H5O7), on the separation of L-tryptophan. It was possible to demonstrate 
that the presence of small quantities of [C4mim]Br enhances up to twice the extraction ability of 
the amino acid for the polymer-rich phase. In a similar work (83), the influence of the addition of 
5 wt% of [C4mim]Br to ABS formed by PEG 600 + K3C6H5O7 was evaluated for the extraction of L-
tyrosine (Tyr).  
Furthermore, Almeida et al. (102) proposed ABS composed of PEG, Na2SO4 and ILs (at 5 or 10 
wt%) as an alternative technique for the extraction, separation and/or purification of gallic, 
vanillic and syringic acids. The results obtained clearly demonstrated the ability of ILs to tune the 
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polarity of the PEG-rich phase and to tailor the extraction of phenolic acids. Furthermore, de 
Souza et al. (81) investigated the impact of several imidazolium-based ILs as adjuvants in the 
formation of ABS constituted by potassium salts, water and PEG (1500, 4000, 6000 and 8000). The 
ILs influence was also evaluated on the partition behavior of Chloranilic Acid and Rhodamine 6G 
(81). Moreover, the same approach was used by Souza et al. (82) in which imidazolium-based ILs 
as adjuvants in polymer-salt ABS were used to purify an enzyme.  
Taking into account the previous works (9,81–84,102), it is possible to conclude that the 
use of ILs as adjuvants to modify the characteristics of the polymer-rich phase could be an 
interesting alternative in separation processes and opens the door for a new range of IL-based 
extraction processes. 
Considering the advantages described before in the use of polymer-salt-based ABS for the 
recovery/purification of IgG, combined with the tailoring ability afforded by ILs, the aim of this 
work consists on the use of ILs as adjuvants in PEG-salt ABS for the separation and purification of 
IgG from rabbit serum. 
  
 
 
 
 
2. Experimental section 
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2.1. Chemicals 
In this work, PEGs with different molecular weights, namely 400, 600, 1000, 2000, 4000 and  
8000 g·mol-1 (herein abbreviated as PEG 400, PEG 600, PEG 1000, PEG 2000, PEG 4000 and PEG 
8000, respectively) were studied. They were obtained from Sigma–Aldrich, with the exception of 
PEG 1000 that was obtained from Fluka The salts used were the potassium citrate tribasic 
monohydrate (K3C6H5O7·H2O, purity ≥ 99 wt%), acquired from Sigma–Aldrich Chemical Co. (USA), 
and citric acid monohydrate, C6H8O7.H2O, from Panreac (EU). 
The water employed was double distilled, passed across a reverse osmosis system and further 
treated with a Milli-Q plus 185 water purification apparatus.  
IgG from rabbit serum (reagent grade, ≥ 95%) as a lyophilized powder, 113.6 mg of solid, was 
purchased from Sigma-Aldrich.  
In this work different ILs were investigated, namely: 1-butyl-3-methylimidazolium bromide, 
[C4mim]Br (purity of 99 wt %); 1-ethyl-3-methylimidazolium chloride, [C2mim]Cl (purity of 99 wt 
%); 1-butyl-3-methylimidazolium chloride, [C4mim]Cl (purity of 99 wt %); 1-hexyl-3-
methylimidazolium chloride, [C6mim]Cl (purity of 99 wt %); 1-octyl-3-methylimidazolium chloride, 
[C8mim]Cl (purity of 99 wt %); 1-decyl-3-methylimidazolium chloride, [C10mim]Cl (purity of 99 wt 
%); 1-dodecyl-3-methylimidazolium chloride, [C12mim]Cl (purity of 99 wt %); 1-tetradecyl-3-
methylimidazolium chloride, [C14mim]Cl (purity of 99 wt %); 1-butyl-3-methylimidazolium 
tosylate, [C4mim][Tos] (purity of 98 wt %); 1-butyl-3-methylimidazolium dicyanamide, 
[C4mim][N(CN)2] (purity > 98 wt %); and 1-butyl-3-methylimidazolium acetate, [C4mim][CH3CO2]. 
The chemical structures of the investigated ILs are depicted in Figure 12. All ILs were purchased 
from Iolitec. Before use, all ILs were purified and dried for a minimum of 24 h, under constant 
agitation, at moderate temperature (≈ 353 K) and under vacuum (to reduce their volatile 
impurities to negligible values). After this step, the purity of each IL was also confirmed by 1H and 
13C NMR spectra and found to be in accordance with the purity levels given by the supplier. 
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Figure 12: Chemical structures of the ILs investigated: (i) [C4mim][Tos]; (ii) [C4mim][N(CN)2]; (iii) 
[C4mim][CH3COO]; (iv) [C4mim][Br]; (v) [C4mim][Cl]; (vi) [C6mim][Cl]; (vii) [C8mim][Cl]; (viii) 
[C10mim][Cl]; (ix) [C2mim][Cl]; (x) [C12mim][Cl]; (xi) [C14mim][Cl]. 
 
2.2. Experimental procedure 
2.2.1. Phase diagrams, tie-lines (TLs) and critical point 
Phase diagrams comprise a binodal curve and different tie-lines (TLs). While the binodal curve 
represents the borderline between the monophasic region and the biphasic region, the TL 
describes the compositions of the two phases in equilibrium for given mixture compositions. The 
respective ternary phase diagrams were determined for each of the water-soluble PEGs (PEG 200, 
PEG 400, PEG 600, PEG 1000, PEG 2000, PEG 4000, PEG 6000 and PEG 8000) at pH ≈ 7 and for PEG 
400 in the range from pH 5 to 9. The buffer solutions (K3C6H5O7/C6H8O7) mixtures were used to 
maintain the pH of the overall ABS at the desired value. The binodal curve of each ABS was 
determined through the cloud point titration method at 25 ⁰C and atmospheric pressure (21), 
using aqueous solution of salt at around 50 wt % and aqueous solutions of the different 
hydrophilic PEGs (with concentrations ranging from 60 wt % to 90 wt %). The experimental 
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procedure has been validated in previous reports (103,104). Repetitive drop-wise addition of the 
aqueous salt solution to the polymer solution, or vice-versa, was carried out until the detection of 
a cloudy solution (biphasic region), followed by the drop-wise addition of ultra-pure water until 
the detection of a clear and limpid solution (monophasic region). This procedure was carried 
under constant stirring. Each mixture composition was determined by the weight quantification of 
all components added within an uncertainty of ± 10-4 g (using an analytical balance, Mettler 
Toledo Excellence XS205 DualRange). 
The TLs of each phase diagram were determined by a gravimetric method originally described 
by Merchuk et al. (105). A mixture at the biphasic region was gravimetrically prepared (PEG + Salt 
+ water) within ± 10-4 g, vigorously stirred, and left for at least 12 h at 25 ⁰C to reach the complete 
separation and equilibration of the coexisting phases. After the separation step, both top and 
bottom phases were weighted.  
The experimental binodal curves were fitted using Equation (1) (105): 
 
[𝑃𝐸𝐺] = 𝐴exp[(𝐵[𝑠𝑎𝑙𝑡]0.5) − (𝐶[𝑠𝑎𝑙𝑡]3)]     (1) 
 
where [𝑃𝐸𝐺] and [𝑠𝑎𝑙𝑡] are, respectively, the PEG and salt weight percentages and 𝐴, 𝐵 and 𝐶 
are constants obtained by the regression. 
Each individual TL was determined by the application of the lever-arm rule to the relationship 
between the top phase weight and the overall system composition. For the determination of TLs 
it was solved the following system of four equations (Equations 2 to 5) and four unknown values 
([𝑃𝐸𝐺]PEG, [𝑃𝐸𝐺]salt, [𝑠𝑎𝑙𝑡]PEG and [𝑠𝑎𝑙𝑡]salt) (105): 
 
[𝑃𝐸𝐺]PEG = 𝐴exp[(𝐵[𝑠𝑎𝑙𝑡]PEG
0.5 ) − (𝐶[𝑠𝑎𝑙𝑡]PEG
3 )]    (2) 
 
[𝑃𝐸𝐺]salt = 𝐴exp[(𝐵[𝑠𝑎𝑙𝑡]salt
0.5 ) − (C[𝑠𝑎𝑙𝑡]salt
3 )]    (3) 
 
[𝑃𝐸𝐺]PEG =
[𝑃𝐸𝐺]M
α
− (
1−α
α
) [𝑃𝐸𝐺]salt           (4) 
 
[𝑠𝑎𝑙𝑡]PEG =
[𝑠𝑎𝑙𝑡]M
α
− (
1−α
α
) [𝑠𝑎𝑙𝑡]salt                  (5) 
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The subscripts PEG, salt and M represent the top, bottom and the mixture phases, 
respectively. The parameter α is the ratio between the PEG-rich phase weight and the total 
weight of the two phases. The solution of the referred system gives the concentration (wt %) of 
the PEG and salt in the top and bottom phases, and thus TLs can be easily represented.  
For the calculation of the tie-line lengths (TLLs) it was applied Equation. (6). 
 
𝑇𝐿𝐿 = √([𝑠𝑎𝑙𝑡]PEG − [𝑠𝑎𝑙𝑡]salt)2 + ([𝑃𝐸𝐺]PEG − [𝑃𝐸𝐺]salt)2                     (6) 
 
The critical point of each ABS was determined by extrapolating the TLs’ slopes of individual 
systems by the fitting provided by Equation (7), 
 
[Salt] =  𝑓[PEG] + 𝑔                (7) 
 
where f and g are fitting parameters. 
 
2.2.2. pH measurements 
The pH values of both the PEG-rich and organic-salt-rich aqueous phases were measured at (25 
± 1) ⁰ºC using a METTLER TOLEDO SevenMulti pH meter within an uncertainty of ± 0.02. 
 
2.2.3. Extraction of IgG using PEG-salt based ABS  
The ternary mixture compositions for the IgG extraction were chosen based on the phase 
diagrams determined for each PEG-C6H5K3O7/C6H8O7. Moreover, to avoid discrepancies in the 
results which could arise from the different compositions between the two phases, all the 
partitioning studies were performed at a constant TLL. The mixture compositions which 
correspond to a TLL of 35 are as follows: 25 wt% of PEG 400 + 25 wt% of C6H5K3O7/C6H8O7, 19 wt% 
of PEG 600 + 23 wt% of C6H5K3O7/C6H8O7, 19 wt% of PEG 1000 + 20 wt% of C6H5K3O7/C6H8O7, 18 
wt% of PEG 2000 + 16 wt% of C6H5K3O7/C6H8O7, 18 wt% of PEG 4000 + 14 wt % of 
C6H5K3O7/C6H8O7, 17 wt% of PEG 6000 + 14 wt % of C6H5K3O7/C6H8O7, and 16 wt% of PEG 8000 + 
15 wt % of C6H5K3O7/C6H8O7. The partition behaviour of rabbit IgG in aqueous PEG/citrate buffer 
two-phase systems was investigated using IgG stock solutions prepared with a concentration at 
circa 1 g.L-1 dissolved in PBS (phosphate buffered saline at 0.01M and pH ≈ 7.4 at 25⁰C). In each 
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system, a small amount of the solution containing IgG (≈ 0.30 mg) was added to the phase-
forming components to reach a total weight of the mixture of 1.5 g. 
In order to elucidate the main factors that rule the partition behavior of IgG in polymer/salt 
ABS, three main parameters were investigated.  
 
Effect of equilibrium time 
Firstly, it was studied the effect of the extraction time. For this purpose, the polymers with 
the highest (PEG 8000) and the lowest (PEG 400) molecular weight were used. The mixtures were 
prepared at pH ≈ 7, same of them were submitted at 10 min by centrifugation at 1000 rpm (VWR, 
Micro Star 17), followed by different times of equilibrium, namely 10, 30, 60, 90 and 120 min of 
rest, while others were left to phase separate (with no centrifugation) for 300 and 720 min at 25 
°C. ABS composed PEG 400, PEG 8000 and PEG 2000, at pH ≈ 7, were also submitted to 
centrifugation for 10 min at 1000 rpm followed by 60, 120 and 180 min of rest at 25° C.  
 
Effect of molecular weight of PEG 
The second parameter studied was the PEG molecular weight (namely, 400, 600, 1000, 2000. 
4000, 6000, 8000 g·mol-1). In this study, mixtures at pH ≈ 7 were prepared and centrifuged for 10 
min, at 1000 rpm, and left to equilibrate for 120 min at 25⁰C to ensure the total phases 
separation.  
 
Effect of pH 
The last parameter comprises the study of the effect of pH through the IgG extraction. In this 
case, mixtures at different pH values (6, 8, and 9) were prepared, centrifuged at 1000 rpm for 10 
min and left to equilibrate for more 120 min at 25 °C, to ensure total phase separation. In this 
part, the mixture compositions which correspond to a TLL of 35 are as follows: 19.88 wt% of PEG 
400 + 35.40 wt% of C6H5K3O7/C6H8O7, at pH ≈ 5; 21.92 wt% of PEG 400 + 29.37 wt % of 
C6H5K3O7/C6H8O7, at pH ≈ 6; 21.42 wt% of PEG 400 + 25.67 wt % of C6H5K3O7/C6H8O7, at pH ≈ 8; 
and 23 wt% of PEG 400 + 25 wt % of C6H5K3O7/C6H8O7, at pH ≈ 9. 
In the studied ABS, the top phase corresponds to the PEG-rich aqueous phase, while the 
bottom phase is mainly composed of salt. After a careful separation of both phases, the 
quantification of IgG in the two phases was carried by UV-spectroscopy, using a UV-
spectrophotometry (SYNERGY|HT microplate reader, BioTek), at a wavelength of 280 nm, using 
calibration curves previously established (cf. Appendix A - Figure A.1). At least three individual 
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experiments were performed in order to determine the average in the partition coefficient, 
extraction efficiency and extraction yields, as well as, the respective standard deviations. The 
interference of the salt and PEG with the quantification method was also ascertained and blank 
control samples were always used. 
The partition coefficient of the studied rabbit IgG, 𝐾IgG, is defined as the ratio of the 
concentration of IgG in the PEG-rich to that in the salt-rich aqueous phase according to Equation 
(8), 
 𝐾IgG =
[IgG]PEG
[IgG]Salt
         (8) 
The percentage extraction efficiency of IgG into to PEG-rich phase, 𝐸𝐸IgG%, is the percentage 
ratio between the amount of protein in the PEG-rich aqueous phase to that in the total mixture, 
and is defined according to Equation (9), 
 
𝐸𝐸IgG% =
𝑤𝐼𝑔𝐺
𝑃𝐸𝐺
𝑤𝐼𝑔𝐺
𝑃𝐸𝐺 +𝑤𝐼𝑔𝐺
𝑆𝑎𝑙𝑡  × 100                                                                           (9) 
 
 
where 𝑤𝐼𝑔𝐺
𝑃𝐸𝐺  and 𝑤𝐼𝑔𝐺
𝑆𝑎𝑙𝑡 are the weight of IgG in the PEG-rich phase and in the salt-rich phase, 
respectively. 
The extraction yield of IgG into to PEG-rich phase, 𝑌IgG%, is the percentage ratio between the 
amount of protein in the PEG-rich aqueous phase to that added in the initial mixture (𝑤𝐼𝑔𝐺
𝐼𝑛𝑖𝑡𝑖𝑎𝑙), 
and is defined according to Equation (10).  
 
𝑌IgG % =
𝑤𝐼𝑔𝐺
𝑃𝐸𝐺
𝑤𝐼𝑔𝐺
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 × 100                                                                                     (10) 
 
 
2.2.4. Extraction of IgG using ILs as adjuvants in PEG-salt based ABS  
After the previously described optimisation procedures, a mixture point, with a composition 
of 25 wt% of PEG 400 + 25 wt% of C6H5K3O7/C6H8O7 at pH ≈ 7 (TLL of 35) was selected. In this 
mixture, 5 wt% of each IL was added, and the partition behaviour of rabbit IgG was investigated. 
The ILs used for the study of the anion effect were: [C4mim]Br; [C4mim]Cl [C4mim][Tos]; 
[C4mim][N(CN)2]; [C4mim][CH3CO2]; while to study the effect of the cation nature the following ILs 
were employed: [C2mim]Cl, [C4mim]Cl, [C6mim]Cl, [C8mim]Cl, [C10mim]Cl, [C12mim]Cl, and 
[C14mim]Cl. The stock solutions were prepared with a concentration at circa 1 g
.L-1 of rabbit serum 
IgG, dissolved in PBS (phosphate buffered saline at 0.01M, pH ≈ 7.4). In each system, a small 
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amount of solution content IgG (≈ 0.30 mg) was added to a total weight of 1.5 g corresponding to 
the ABS. Each mixture was then stirred, centrifuged for 10 min, at 1000 rpm, at 25⁰C, and left to 
equilibrate for more 120 min (a time period established in the previous optimization experiments) 
in order to achieve the complete partitioning of IgG between the two phases. Again, the PEG-rich 
phase is the top layer, while the salt-rich phase corresponds to the bottom layer.  
After a careful phase separation, the top phase sample was diluted. Subsequently, 𝐾IgG% 
was assessed using equation (8), 𝐸𝐸IgG% was determined using equation (9) and 𝑌IgG% was 
determined using equation (10). These parameters were evaluated using data obtained by UV-
spectroscopy, using a (SYNERGY|HT microplate reader, BioTek), at a wavelength of 280 nm. 
Furthermore, the partition coefficient of the IL, 𝐾IL, is defined as the ratio of the IL in the PEG-rich 
to that in the salt-rich aqueous phase according to Equation (11), 
 𝐾IL =
AbsIL
𝑃𝐸𝐺
Abs𝐼𝐿
𝑆𝑎𝑙𝑡         (11) 
 
where AbsIL
PEG and AbsIL
Salt are the absorbance of IL at the maximum wavelength (211 nm), 
adjusted by the respective dilution factor, in the PEG-rich and in the salt-rich aqueous phases, 
respectively. 
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3.1. Phase diagrams, tie-lines (TLs) and critical point 
 
3.1.1. Effect of the molecular weight of PEG 
The development of more efficient, economic and environmentally-friendly processes to 
extract and purify biopharmaceuticals, while envisaging their large scale applications, is a vital 
requirement. Thus, in this work, polymer-organic-salt-based ABS, as well as ABS employing ILs as 
adjuvants, were used to evaluate their extraction ability for IgG before moving to real serum 
samples. The organic salt and the polymers used are of low cost, biodegradable and non-toxic 
compounds (7,8).  
The ternary phase diagrams were determined at 25 ⁰C for several PEGs with different 
molecular weights (PEG 200, 400, 600, 1000, 2000, 4000, 6000 and 8000) and the citrate buffer at 
pH ≈7 in aqueous medium. The phase diagrams obtained are illustrated in Figure 13 (the 
experimental weight fraction data of each phase diagram are given at Appendix B, Table B. 1 to 
Table B. 4). The respective phase diagrams in molality units are presented in Appendix C, in Figure 
C. 1. For all the studied ABS, the top phase corresponds to the aqueous PEG-rich phase while the 
bottom phase is mainly composed of C6H5K3O7/C6H8O7 and water. The results for PEG 200 are not 
showed, since after several experimental attempts, it was found that there is no formation of a 
biphasic system between PEG 200 and C6H5K3O7/C6H8O7 at pH ≈ 7. 
By plotting each phase diagram (Figure 13), it is possible to realize the influence of the length 
of the PEG chains on the phase diagram behavior, and on the PEG ability to create ABS. In all 
phase diagrams, the biphasic region is localized above the solubility curve, and larger this region 
is, the higher is the ability of PEG to undergo liquid-liquid demixing in the presence of 
C6H5K3O7/C6H8O7 at pH ≈7. In general, for polymers of lower molecular weight the phase 
separation only occurs at higher concentrations of PEG. Thus, with the increase of the PEG 
molecular weight, it increases their ability to form ABS systems, and in the following order: PEG 
400 < PEG 600 < PEG 1000 <PEG 2000 < PEG 4000 < PEG 6000 < PEG 8000. Similar trends have 
been observed in other ABS composed of polymer/salt or PEG/IL pairs (21,102,106,107). This 
behavior is a consequence of the higher hydrophobicity displayed by PEGs of higher molecular 
weight, i.e., they present a lower affinity for water, and are more easily excluded for a second 
liquid phase by the salting-out species (C6H5K3O7/C6H8O7). The systems composed of PEG 1000, 
2000, 4000 and 6000 and potassium citrate and water have been reported in the literature being 
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the results obtained in close agreement with literature data (107) - Appendix C, Figure C. 2. 
Nevertheless, for PEGs of lower molecular weight novel experimental data are here shown. 
 
 
Figure 13: Evaluation of the molecular weight of PEG in the ternary phase diagrams composed of  
PEG + C6H5K3O7/C6H8O7 + H2O: PEG 400 (); PEG 600 (×); PEG 1000 (); PEG 2000 (); PEG 4000 (); PEG 
6000 () PEG 8000 (), and critical points of each system (). 
 
For the studied systems, the experimental binodal data were further fitted by the empirical 
relationship described by Equation (1). The regression parameters A, B and C, were estimated by 
the least-squares regression method, and their values and corresponding standard deviations (σ) 
are provided in Table 6. In general, good correlation coefficients were obtained for all systems, as 
it is possible to confirm in Figure 13, indicating that these fittings can be used to predict data in a 
given region of the phase diagram where no experimental results are available. 
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Table 6: Correlation parameters used to describe the experimental binodal data by Equation (1). 
PEG              A ± σ                B ± σ    10
5 
(C ± σ)      R
2
 
400 167.4 ± 2.7 -0.360 ± 0.005 1.67  ± 0.67 0.9971 
600 126.0 ± 0.9 -0.355 ± 0.003 3.36 ± 0.06 0.9986 
1000 198.9 ± 7.3 -0.479 ± 0.012 5.06 ± 0.21 0.9981 
2000 135.6 ± 6.0 -0.507 ± 0.016 9.83 ± 0.54 0.9991 
4000 172.0 ± 17.7 -0.642 ± 0.039 14.6 ± 1.68 0.9983 
6000 337.1 ± 38.2 -0.872 ± 0.041 16.3 ± 1.44 0.9953 
8000 160.2 ± 138.4 -0.583 ± 0.292 37.6 ± 8.16 0.9947 
 
The experimental TLs, along with their respective length (TLL), are reported in Table 7 as well 
as the composition of each system and respective pH values. An example of the TLs obtained is 
depicted in Figure 14; in general, the TLs are closely parallel to each other. In addition, the critical 
point of each system was also determined using equation (7) based on a geometrical approach 
schematized in Figure 14 for the system composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O at pH 7. 
Their respective detailed data are presented in Appendix C, Table C. 1. In general, the contents of 
salt and PEG at the critical point are similar amongst the different systems, although the amount 
of each compound decreases with the increase of the PEG hydrophobicity – a consequence of 
their higher ability to create ABS.  
 
Figure 14: Phase diagram for the ternary system composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O at pH 7, at 
25 ⁰C: binodal curve data (,); TL data (); adjusted binodal data through Equation 1 (-), critical point () 
and TL relation (). 
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Table 7: Experimental data of TLs and TLLs of ABS composed of PEG + C6H5K3O7/C6H8O7. 
PEG  N.º 
Weight fraction composition / wt % 
TLL α 
[PEG]PEG [BUFFER]PEG pHPEG [PEG]M [BUFFER]M [PEG]BUFFER 
[BUFFER] 
BUFFER pHBUFFER 
400 
 
1 74.83 4.97 7.10 34.54 25.18 6.35 39.31 6.64 76.60 0.41 
 
2 42.43 13.64 6.82 24.86 24.64 11.78 32.83 6.80 36.17 0.57 
 
3 69.47 5.94 6.54 32.40 24.40 8.71 36.20 7.09 67.88 0.61 
 
4 65.91 6.66 6.49 31.17 24.00 10.24 34.45 6.98 62.22 0.62 
 
5 41.33 14.09 6.92 34.72 18.29 11.73 32.88 6.37 35.06 0.78 
600 
 
1 39.94 9.88 6.93 33.04 15.00 2.29 37.86 6.29 46.91 0.82 
 
2 34.81 11.96 6.71 18.86 23.32 4.56 33.50 6.58 37.14 0.47 
 
3 39.94 9.88 6.93 33.04 15.00 2.29 37.86 6.29 46.91 0.82 
1000 
 
1 55.62 6.90 6.22 26.18 24.61 0.90 40.15 6.30 64.49 0.47 
 
2 50.90 7.81 5.99 31.31 19.52 0.68 37.81 6.22 58.50 0.61 
 
3 36.65 11.39 6.17 19.39 20.72 4.61 28.71 6.19 36.41 0.46 
2000 
 
1 36.88 16.06 6.82 24.86 24.64 8.73 36.15 6.80 34.59 0.57 
 
2 51.33 10.46 6.54 32.40 24.40 2.80 46.20 7.09 60.30 0.61 
 
3 47.87 11.62 6.49 31.17 24.00 3.47 44.54 6.98 55.26 0.62 
 
4 30.28 19.46 6.64 24.33 23.50 15.35 29.59 6.75 18.04 0.60 
4000 
 
1 51.49 3.49 6.83 24.90 19.99 0.01 35.44 6.51 60.59 0.52 
 
2 42.23 4.68 6.79 24.75 15.04 0.12 29.65 6.48 48.95 0.58 
 
3 31.33 6.68 6.63 17.52 14.18 1.34 22.98 6.50 34.13 0.54 
6000 
 
1 21.53 9.09 6.41 15.05 12.03 4.22 16.94 6.37 19.00 0.63 
 
2 24.97 8.29 6.45 15.07 12.81 2.94 18.35 6.37 24.22 0.55 
 
3 27.33 7.80 6.45 12.22 14.96 1.95 19.82 6.32 28.08 0.40 
 
4 31.21 7.09 6.51 17.42 13.86 1.02 21.92 6.30 33.64 0.54 
8000 
 
1 23.49 8.45 6.42 12.02 14.16 0.64 19.83 6.41 25.53 0.50 
 
2 21.31 8.98 6.31 6.04 16.03 1.40 18.18 6.30 21.94 0.23 
 
3 30.03 7.02 6.53 16.46 14.10 0.13 22.61 6.37 33.72 0.55 
 
4 30.70 6.89 6.51 15.54 14.77 0.12 22.78 6.34 34.47 0.50 
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3.1.2. Effect of pH on the formation of PEG-salt based ABS 
Aiming at studding the effect of pH on the ABS formation capacity, the respective liquid-liquid 
ternary phase diagrams for the system composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O were 
determined at different pH values (5-9), using different ratios of potassium citrate and citric acid 
(C6H5K3O7/C6H8O7). The phase diagrams obtained are depicted in Figure 15 (the experimental 
weight fraction data of each phase diagram are depicted in Appendix B, Table B. 5 and B. 6). The 
respective phase diagrams in molality units are presented in Appendix C, in Figure C. 3. It can be 
seen that the binodal curves have similar shapes for the different pH values, and that an increase 
in the pH leads to a higher ability for liquid-liquid demixing, being in agreement with literature for 
systems composed of polymers and other salts (108). Note that, in general, the ability for ABS 
formation as a function of pH is strongly related with the speciation behaviour of citric acid or 
potassium citrate. Table 8 presents the pKa values of citric acid. At pH values below 3.05 the non-
charged citric acid is mainly present. At pH values above 4.67 and 5.39 there is the prevalence of 
the divalent and trivalent charged hydrogenocitrate and citrate anions, respectively (a weaker 
salting-out species if compared with the trivalent citrate anion). The same tendency was already 
observed for IL-salt based ABS (109). It should be remarked that the phase diagram at pH 9 has 
already been reported by Lu et al. (110), and the results obtained here display a good agreement 
with the literature (Appendix C, Figure C. 2). 
 
Table 8: pKa values of citric acid at 25 ⁰C (111). 
pKa1  pKa2   pKa3   pKa4  
3.05 4.67 5.39 13.92 
 
The experimental binodal data were further fitted by the empirical relationship described by 
equation (1), with the respective representation shown in Figure 15, and the fitting parameters, 
standard deviations (σ) and correlation coefficients (R2) are provided in Table 9. The experimental 
binodal data obtained lead to improved correlation coefficients indicating that these fittings can 
be used to predict data in a given region of the phase diagram where no experimental results are 
available.  
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Figure 15: Ternary phase diagrams for systems composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O at 25 ⁰C and 
atmospheric pressure at different pH values: pH 5 (×), pH 6 (), pH 7 (), pH 8 () and pH 9 (), critical 
point (). 
 
The TLs, along with their respective length (TLL), are reported in Table 9. In addition, the 
critical point of each system is also depicted in Figure 15 with the detailed data shown in 
Appendix C, Table C. 2. In general, the compositions of the critical point become richer in PEG and 
poorer in salt with the increase of the pH. 
 
Table 9: Correlation parameters used to describe the experimental binodal data by Equation 1. 
PEG pH A ± σ B ± σ 10
5 
(C ± σ) R
2
 
400 
5 131.9 ± 2.1 -0.253 ± 0.006 1.10 ± 0.09 0.9979 
6 153.8 ± 3.0 -0.320 ± 0.007 1.51 ± 0.10 0.9967 
7 167.4 ± 2.7 -0.360 ± 0.005 1.67 ± 0.67 0.9971 
8 127.2 ± 1.6 -0.305 ± 0.005 2.07 ± 0.10 0.9971 
9 119.4 ± 1.2 -0.285 ± 0.004 2.34 ± 0.08 0.9979 
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Table 10: Experimental data for TLs and TLLs of IL + C6H5K3O7/C6H8O7 ABS, initial mixture compositions 
([PEG]M and [salt]M), and pH values of the coexisting phases. 
PEG pH N.º 
Weight fraction composition / wt % 
TLL α 
[PEG]PEG [BUFFER]PEG pHPEG [PEG]M [BUFFER]M [PEG]BUFFER 
[BUFFER] 
BUFFER 
pH BUFFER 
400 
5 
1 63.58 8.20 5.66 28.64 35.35 3.19 55.13 5.51 76.48 0.58 
2 36.67 21.48 5.41 20.50 35.53 7.60 46.74 5.38 38.51 0.44 
3 32.90 23.97 5.43 19.88 35.40 8.71 45.21 5.36 32.19 0.46 
6 
1 44.88 13.87 6.27 30.26 24.96 5.03 44.09 6.02 50.01 0.63 
2 50.57 11.59 6.27 32.24 26.13 2.53 49.69 6.11 61.32 0.62 
3 37.87 17.16 5.93 21.92 29.37 7.31 40.57 5.93 38.49 0.48 
4 74.83 4.97 7.10 34.54 25.18 6.35 39.31 6.64 76.60 0.41 
5 42.43 13.64 6.82 24.86 24.64 11.78 32.83 6.80 36.17 0.57 
8 
1 47.16 10.13 7.76 26.99 25.38 3.12 43.44 7.70 55.22 0.54 
2 49.13 9.38 7.77 29.91 24.52 2.15 45.97 7.78 59.55 0.59 
3 40.01 13.21 7.64 24.24 24.46 7.38 36.49 7.63 40.09 0.52 
4 36.67 10.13 7.76 21.42 25.68 9.19 34.36 7.61 33.69 0.45 
9 
1 48.19 9.68 7.86 27.01 25.02 3.30 55.55 8.04 55.55 0.53 
2 49.93 9.01 7.91 30.01 24.03 2.06 59.96 8.11 59.96 0.58 
3 40.69 2.97 7.84 24.25 24.25 8.11 35.01 7.90 39.33 0.50 
4 35.80 15.43 7.72 22.76 24.81 7.33 35.05 8.11 35.05 0.54 
 
The pH values of the systems composed of PEG + C6H5K3O7/C6H8O7 + H2O are in the 
acid/neutral region (pH = 6 - 8) initially estimated and differences promoted by PEG practically 
were not observed in the buffered systems. 
 
3.2. Extraction of IgG using PEG-salt based ABS 
3.2.1. Extraction time 
After the determination of all phase diagrams and respective TLs and TLLs, which allow to infer 
on the mixture compositions required to form two-phase systems, the following mixture 
compositions at pH ≈ 7 were applied to the extraction of IgG: 25 wt% of PEG 400 + 25 wt% of 
C6H5K3O7/C6H8O7, 18 wt% of PEG 2000 + 16 wt% of C6H5K3O7/C6H8O7, and 16 wt% of PEG 8000 + 15 
wt % of C6H5K3O7/C6H8O7 (which correspond to a TLL of circa 35). This study was carried out in 
order to understand the best time conditions for the extraction and purification of IgG (aiming at 
avoiding precipitation and denaturation effects while guarantying the equilibrium conditions). 
Pure IgG aqueous solutions were used at this stage. The first extractions were carried out with the 
ABS composed of the lower and highest molecular weight PEGs, namely 400 and 8000 g·mol-1. It is 
important to refer that in the systems composed of PEG 400 the protein precipitation was not 
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observed, while all samples composed of PEG 8000, exposed at different times of extraction 
demonstrated as the presence of some precipitated proteins, as shown in Figure 16. Thus, based 
on these visual inspections, the results shown in Figure 17, with the respective data in Appendix 
D, Table D.1, confirm the higher yield of IgG (YIgG) obtained with the systems composed of PEG 
400. In particular, the best results were obtained with the phases’ separation promoted by 
centrifugation at 1000 rpm for 10 min followed by 120 min of rest, and for the 300 and 720 min 
without the use of centrifugation.  
 
 
Figure 16: Extraction of IgG using ABS constituted by PEG + C6H5K3O7/C6H8O7 at 25 ⁰C, a) PEG 400 and  
b) PEG 8000. 
 
Although with the systems formed by PEG 400 it was not visually detected the protein 
precipitation, yields lower than 50 % were obtained in all studies – Figure 17. The low amounts of 
protein loss are not macroscopically seen. In all situations, PEG 400 leads to higher extraction 
efficiencies when compared with the results afforded by PEG 8000. IgG preferentially migrates for 
the polymer-rich phase in systems composed of PEG 400 (EEIgG % ranging between 88 and 96 %), 
while the results obtained for PEG 8000 show a more distinct behavior and preferential extraction 
to the polymer- or salt-rich phases depending on the conditions applied to promote the phase 
separation (EEIgG % ranging between 23 and 66 %). These more pronounced differences can be a 
direct result of the higher viscosity of aqueous solutions of PEG 8000. Moreover, and for the 
results in which centrifugation was applied, PEG 400 leads to lower losses of protein. 
a) b)
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Figure 17: Extraction efficiencies (EEIgG %) and extraction yields (YIgG %) of IgG using ABS composed of PEG 
400 and PEG 8000 at pH≈7 and at 25 ⁰C: EEIgG % PEG 400 () and YIgG % (——); EEIgG % PEG 8000 () and YIgG 
% (——). Extraction times of 10 to 120 min, before 10 min of centrifugation at 1000 rpm and 300 and 720 
min without centrifugation.  
 
Andrews et al. (68) demonstrated that hydrophobic proteins partition preferentially to the 
PEG-rich phase in polymer-salt ABS (68). Thus, it is expected that IgG has a higher preference for 
the polymer-rich phase when more hydrophilic polymers (of lower molecular weight) are used 
considering its large its low surface hydrophobicity, 14% (6,44). Moreover, due to the high IgG 
molecular weight (150 kDa) size-exclusion effects are also observed in systems constituted by 
polymers of higher molecular weight. These trends can be observed in more detail by the analysis 
of the partition coefficients represented in Figure 18. In all situations, the partition coefficients 
(Appendix D, Table D. 1) obtained with the systems formed by PEG 400 are higher than those 
observed with the ABS formed by PEG 8000.  
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Figure 18: Partition coefficient of rabbit IgG (KIgG) in different ABS, composed of PEG 400 and PEG 8000 at 
pH≈7 and at 25 ⁰C: PEG 400 () and PEG 8000 ().Extraction times of 10 to 120 min, before 10 min of 
centrifugation at 1000 rpm and 300 and 720 min without centrifugation.  
 
As the PEG alkyl chain length decreases, there will be less ethylene oxide groups per PEG 
molecule, for the same concentration of polymer, and hence the top phase will be less 
hydrophobic. On the other hand, a decrease in the PEG molecular weight leads to a decrease in 
the steric exclusion of proteins from the PEG-rich phase (6). In fact, our results suggest that lower 
molecular weight PEGs are favourable for the partitioning of IgG, and as previously suggested by 
Yan-Min et al. (107) who reported the extraction and back-extraction of bovine serum albumin 
(BSA) with PEG/potassium citrate ABS, as well as in the studies of Aires Barros et al. (3) regarding 
the IgG partition in PEG/ phosphate (with 15% of NaCl). 
After the analysis of the previous results, the best conditions for the systems composed of 
PEG 400 and 8000 were chosen and another time of equilibrium, 180 min, was included to 
complete this study. However, short times of extraction were chosen to avoid the contact of the 
protein for long periods when the IL is included as well as aiming at developing a scalable 
technique. The subsequent studies were performed submitting the systems at different times of 
rest namely, 60, 120 and 180 min. Before, the same systems were submitted to 10 min of 
centrifugation, at 1000 rpm. This procedure was applied also to the ABS composed of PEG 2000.  
The results obtained in terms of extraction efficiencies are depicted in Figure 19. Higher EE% 
values were obtained for PEG 400. Moreover, as expected by the previous results, the best yields 
were obtained for PEG 400, then for PEG 2000 and finally for PEG 8000 (the respective values are 
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presented in Appendix D, Table D. 2). However, in average, there is a loss of IgG of about 60%. The 
only exception was for PEG 2000 with 180 min of rest, where it was observed a loss of the protein 
around 35%. This result is however not very consistent, because in this ABS it was possible to see 
a significant amount of precipitated proteins, such as in the same type of ABS for the others two 
times of extraction. Taking into account that all samples composed of PEG 2000 and 8000 shown 
turbidity (protein precipitation in the systems interface), the values determined (EEIgG %, KIgG and 
YIgG %) may not be completely accurate. 
As expected by the previous results, IgG preferentially migrates for the PEG-rich phase (TP) in 
the cases where the polymer has a lower molecular weight, and as shown in the partition 
coefficients trend shown in Figure 20. 
 
 
Figure 19: Percentage extraction efficiencies (EEIgG %) and extraction yield (YIgG %) of IgG using different ABS 
composed of PEG 400, 2000 and PEG 8000 at pH≈7 and at 25 ⁰C: EEIgG % PEG 400 () and YIgG % (——); EEIgG 
% PEG 2000 (); and YIgG % (——); EEIgG % PEG 8000 () and YIgG % (——).  
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Figure 20: Partition coefficient of rabbit IgG (KIgG) in different ABS, composed of PEG 400, 200 and 8000 at 
pH≈7 and at 25 ⁰C: KIgG PEG 400 ();KIgG PEG 2000 ();KIgG PEG 8000 (). 
 
The best results, taking into account the IgG extraction efficiency and yield, were achieved 
with 120 min of rest time before the 10 min of centrifugation at 1000 rpm. Thus, this procedure 
was applied to the remaining and subsequent experiments. 
 
3.2.2. Effect of the polymer molecular weight 
In this section, the extraction and yield of IgG using ABS  composed of PEGs of different 
molecular weight  + C6H5K3O7/C6H8O7 + H2O (pH ≈ 7) were investigated. For the interpretation of 
results, it is necessary to take into account the findings of P. A. Albertsson (112), who described a 
model for the partition of proteins, where the partition coefficient (K) can be affected by different 
factors, such as salt type and concentration, pH and temperature, as well as the electrochemical, 
hydrophobic and size of the proteins. Later, a linear relation was proposed by Asenjo et al. (113) 
to relate the partition coefficient and the hydrophobicity of proteins in ABS. In summary, the 
partition of proteins in ABS are dependent on hydrophobic-type interactions, electrostatic forces, 
molecular size, solubility, and affinity for both phases, and their magnitudes further depend on 
the two-phase compositions and on the nature of the phase-forming components (9).  
Furthermore, in the systems studied of the type polymer-salt, the K of proteins is mainly 
governed by volume exclusion (polymer-rich phase) and salting-out effects (salt-rich phase) (62). 
However, electrostatic interactions cannot be discarded if extractions are being carried out at pH 
values different from the protein pI as well as hydrogen-bonding interactions, which seem 
particularly relevant in water-rich media. According to the literature, PEGs of higher molecular 
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weight lead to lower extraction efficiencies for the polymer-rich phase due to volume-exclusion 
effects (3,114). According to our results, shown in Figures 21 and 22, a similar trend was observed. 
Nevertheless, the overall size-exclusion (115,116) and salting-out effects (115,116), as well as 
specific interactions  (117), cannot be discarded through the IgG partitioning.  
 
 
Figure 21: Percentage extraction efficiencies (EEIgG %) and yield (YIgG%) of rabbit IgG in different ABS formed 
by PEG 400 to PEG 8000 at pH≈7 and at 25 ⁰C: EEIgG % for PEG 400 (), PEG 600 (), PEG 1000 (), PEG 2000 
(), PEG 4000 (), PEG 6000 (), PEG 8000 (). The line corresponds to the recovery yields of IgG in the 
same systems YIgG % (——). 
 
The best results, in terms of EEIgG % and YIgG %, were achieved with the systems formed by 
PEG 400 and PEG 600 (Appendix D, Table D. 3). These results demonstrate that polyclonal 
antibodies have a higher tendency to migrate to the PEG-rich phase for lower molecular weight 
PEGs. For the remaining tested PEGs (1000, 2000, 4000, 6000 and 8000 g·mol-1), the EEIgG % and K 
values were lower than those observed for the systems formed by PEG 400 or 600, in addition 
that protein precipitation and turbidity was macroscopically visible with PEG 2000, 4000, 6000 
and 8000. This evidence was previously described by Rosa et al. (6), in which the protein 
precipitation was observed for higher PEG molecular weights, leading to lower yields.  
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Figure 22: Partition coefficient (KIgG) of rabbit IgG in different ABS composed of PEG 400 to PEG 8000 at 
pH≈7 and at 25 ⁰C: PEG 400 (), PEG 600 (), PEG 1000 (), PEG 2000 (), PEG 4000 (), PEG 6000 (), 
PEG 8000 ().  
 
Taking into account the results obtained for EEIgG %, YIgG % and KIgG, and the best results 
achieved with the low molecular weight polymers, the following experiments were carried out 
with ABS formed by PEG 400.  
 
3.2.3. Effect of pH 
The pI of rabbit IgG is 7.8, meaning that at this pH the protein has a nearly zero net charge and 
thus no electrostatic interaction occur (116) while protein-polymer interactions seem to 
determine the partition behavior (118,119). It was already demonstrated that the pH in PEG/salt 
systems affect the partition of IgG (114,120). In fact, several researchers reported that at higher 
pH values the negatively charged biomolecule prefers the top phase (polymer-rich) (120). The 
extraction efficiencies and recovery yield of IgG in ABS composed of PEG 400 + C6H5K3O7/C6H8O7 + 
H2O at different pH values and at 25 ⁰C are shown in Figure 23 (detailed data in Appendix D, Table 
D. 4). In all systems, EEIgG% higher than 95% and YIgG% ranging between 46 and 49 % were 
obtained. Although no major differences are observed in the extraction efficiencies, the partition 
coefficients shown in Figure 24, confirm the affinity of IgG for the polymer-rich phase, which is 
increased at the pH values of 8 and 9. 
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Figure 23: Percentage extraction efficiencies of rabbit IgG (EEIgG%) in the ABS composed of PEG 400 + 
C6H5K3O7/C6H8O7 + H2O at different pH values and at 25 ⁰C. The line corresponds to the recovery yields of 
IgG in the same systems YIgG % (——). 
 
 
Figure 24: Effect of pH on the partition coefficient of rabbit IgG (KIgG) in the ABS composed of PEG 400 + 
C6H5K3O7/C6H8O7 + H2O at different pH values and at 25 ⁰C. 
 
When the pH is increased, the protein becomes more negatively charged. Aires Barros et al. (2) 
evaluated the extraction and precipitation of human IgG at different pH values, ranging from 3 to 
8, with PEG 3350/Dextran systems. The authors (2) observed a severe precipitation (over 50%) in 
the pH range 5–8; but at more acidic values precipitation was considerable reduced. In our study, 
the precipitation of the protein was not macroscopically visible although our yields of IgG are 
always below 50% and with no major differences amongst the several pH values investigated 
(Figure 23). Therefore, further studies at lower pH values must be conducted in the near future 
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trying at overcoming this large loss of IgG with the systems investigated. Hatta et al.(36) studied 
the IgG stability and specific activity as a function of temperature and pH by differential scanning 
calorimetry (DSC) and ELISA. It was demonstrated that IgG is stable at 60 °C – 70 °C for 10 min 
while an activity loss of IgG of 10% occurs at pH values from 4-9 at 37 ⁰C (36). Since no major 
differences were observed at the pH values investigated, the remaining studies were carried out 
at the initial pH value, pH ≈7. 
 
3.3. Extraction of IgG using ILs as adjuvants in PEG-salt based ABS  
3.3.1. Effect of the IL anion 
The capacity to extract and partition IgG into PEG 400 + C6H5K3O7/C6H8O7 + H2O (pH≈7) ABS, in 
the presence of various ILs, was investigated herein. This study started taking account the effect 
of the IL anion nature through the IgG extraction and recovery, by keeping the IL with a common 
imidazolium cation ([C4mim]
+) combined with the following anions: Cl-, [TOS]-, Br-, [CH3CO2]
- and 
[N(CN)2]
-. A common mixture composition was chosen 25 wt% of PEG 400 + 25 wt% of 
C6H5K3O7/C6H8O7 + 5% IL , pH ≈ 7 at 25 ⁰C with the addition of several ILs at 5 wt% to the overall 
mixture. Figure 25 depicts the extraction efficiency of IgG in the several systems investigated (the 
respective values are presented in Appendix D, Table D. 5). According to the obtained results, the 
EEIgG% follows the IL anions trend: [TOS]
- ≈ [CH3CO2]
- ≈ Cl- > [N(CN)2]
- > Br-. In summary. an increase 
in the EEIgG% from 96 % (with no IL added) to 100% or complete extraction in a single-step was 
observed with the systems composed of 5 wt% of the following ILs: [C4mim][TOS], 
[C4mim][CH3CO2] and [C4mim]Cl. On the other hand, the systems with [C4mim]Br lead to EEIgG% 
89%, respectively, i.e., a decrease on the EEIgG% when compared with the ABS where no IL was 
added (Figure 25). However, this IL leads to a slight increase on the recovery yield of IgG. The 
hydrogen-bond basicity is a measure of the ability of a compound to accept a proton (or donate 
an electron pair) in a solute-solvent hydrogen-bond (121). In fact, the values of the IL anions 
hydrogen-bond basicity follows the rank: [CH3CO2]
- > Cl− > Br− > [N(CN)2]
−  (121), meaning that a 
decrease on the IL anion hydrogen-bond basicity leads to a decrease on the extractions 
efficiencies. These results are also in accordance with the Hofmeister series where stronger 
salting-out anions induce the protein precipitation (122).  
 
 
 
 
Results and discussion 
53 
 
 
Figure 25: Percentage extraction efficiencies of rabbit IgG, EEIgG%, using ABS composed of PEG 400 + 
C6H5K3O7/C6H8O7 + H2O and [C4mim]-based ILs at 5 wt%, at pH≈7 and 25 ⁰C. The first bar corresponds to the 
ABS where no IL was added. The line corresponds to the recovery yields of IgG in the same systems YIgG % 
(——). 
 
Kosmotropic cations (strongly hydrated) are considered as ‘structure-makers’ because they 
increase the protein stability in solution. On the other hand, chaotropic ions (weakly hydrated) are 
the ‘structure breakers’ and decrease the stability of proteins in aqueous medium (122). The 
Hofmeister series is shown in Figure 26 (123).  
 
 
Figure 26: The Hofmeister series and the ions ranking (adapted from (124)). 
 
3.3.1. Effect of the IL cation 
The effect of the IL cation alkyl side chain length was finally ascertained, using 5 wt% 
[Cnmim]Cl (n = 2, 4, 6, 8, 10, 12 and 14) in the ABS formed by 25 wt% of PEG 400 + 25 wt% of 
C6H5K3O7/C6H8O7 + 5% IL , pH ≈ 7 at 25 ⁰C. For the common mixture composition used the results 
show that EEIgG% decreases in the order: [C2mim]Cl ≈ [C4mim]Cl ≈ [C6mim]Cl ≈ [C12mim]Cl > 
[C14mim]Cl > [C10mim]Cl > [C8mim]Cl (Figure 27, with the respective values presented in Appendix 
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D, Table D. 6). With [C2mim]Cl, [C4mim]Cl, [C6mim]Cl and [C12mim]Cl the EEIgG% obtained reached 
100%, i.e., a complete extraction of IgG for the polymer-rich phase in a single step. However, the 
YIgG% in these systems ranges between 22 and 36 %. Remarkably, the ABS composed of [C10mim]Cl 
led to a significant increase in the IgG stability and recovery, and from 40 % (where no IL was 
added) to 81 % (Figure 27). A possible explanation, is the fact that an increase of the cation/anion 
alkyl side chain length leads to an increase on the IL hydrophobicity (9), and it was already 
reported that proteins are more stable in hydrophobic ILs (125). Others studies in the literature 
demonstrated that [C8mim]- and [C10mim]-based ILs are good candidates for the extraction of 
proteins. Ventura et al. (126) demonstrated the activity increase of an enzyme promoted by the 
self-aggregation of [C10mim]Cl. The self-aggregation of the IL is responsible for the increase in the 
IL–water interface, and consequently, for the increase in the enzyme activity and stability. Souza 
et al. (82) additionally demonstrated that the use of [C8mim]Cl as an adjuvant promotes the 
preferential partition of the proteins for the top phase of a conventional ABS (PEG-rich phase). 
 
Figure 27:Percentage extraction efficiencies of rabbit IgG, EEIgG% ,for different chain length of [Cnmim]Cl (n = 
2, 4, 6, 8, 10, 12, 14): ABS composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O and [Cnmim]Cl at 5 wt%, at pH≈7 
and 25 ⁰C. The first bar corresponds to the ABS where no IL was added. The line corresponds to the 
recovery yields of IgG in the same systems YIgG % (——). 
 
Comparing the results obtained with the ABS composed of 5 wt% of different ILs shown 
inError! Reference source not found.Figure 27, added as adjuvants to PEG 400 + C6H5K3O7/C6H8O7 
+ H2O at pH ≈ 7 ABS, it can be concluded that most of the ILs lead to an increase in the EEIgG%. To 
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other ABS with 5% IL, EEIgG % was possible to obtain 100 %. In terms of YIgG % was shown it is also 
possible to improve. Moreover, Ranyere L. S. et al., study the use of imidazolium-based ILs as 
adjuvants (5 wt%) in ABS of polyethylene glycol systems (1500, 4000, 6000 and 8000 g mol−1) with 
potassium phosphate buffer at pH 7, in the extraction and purification of a lipase, and obtained a 
high purification factor (82).  
In summary, the use of ILs as adjuvants allows to tailor either the extraction efficiency or the 
recovery yield of IgG. Form the obtained results, the correct choice of the anion and cation that 
composes a given IL can allow the increase of both the extraction efficiency and yield. However, 
further studies are still required at this stage, namely on the study of the concentration of the 
[C10mim]Cl in order to check if higher extraction efficiencies and recoveries of IgG can be even 
attained. 
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4. Final remarks  
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4.1. Conclusions 
The main purpose of this work consisted on the development of an alternative and efficient 
approach for the extraction and purification of immunoglobulin G. To this end, the binodal curves 
of ABS composed of different PEGs (400, 600, 1000, 2000, 4000, 6000 and 8000) and 
(K3C6H5O7/C6H8O7) at pH ≈7 at 25 ⁰C were determined. The ABS formation ability follows the 
trend: PEG 8000 > PEG 6000 > PEG 4000 > PEG 2000 > PEG 1000 > PEG 600 > PEG 400, meaning 
that higher molecular weight polymers are more able to form ABS in the presence of a given salt. 
Further, the binodal curves for the ABS formed by PEG 400 and K3C6H5O7/C6H8O7 at different pHs 
(5 to 9) were determined. The ability of K3C6H5O7/C6H8O7 to induce the formation of PEG-based 
ABS decreases with an increase in the pH of the medium. In addition, several TLs and respective 
TLLs were also determined to characterize the investigated systems. In summary, these 
experiments were carried out to characterize the ABS under investigation, aiming at inferring on 
the mixture compositions required to form two-phase systems and to work at similar TLLs during 
the partition experiments. 
Regarding the extraction experiments, initially, the operational conditions used for the two-
phase separation were evaluated in terms of extraction efficiency and recovery yield of IgG. 
Afterwards, the molecular weight of PEG as phase-forming components of ABS was evaluated. 
Extraction efficiencies of 96 % and 98 % were obtained for the systems composed of PEG 400 and 
PEG 600, respectively. Moreover, in terms of YIgG%, the best results achieved were also with PEG 
400 (40 %) and PEG 600 (44 %). The pH of the ABS were also tested; yet, in the pH range evaluated 
(6-9) no significant differences were observed in terms of EEIgG% (95 to 97%) and recovery yields 
(40 to 49 %). 
Finally, and aiming at both increasing the extraction efficiency and recovery yield of IgG, it 
was explored the use of ILs as adjuvants in ABS. Several ILs were tested in order to analyse the IL 
cation alkyl side chain length and anion influence. EEIgG% of 100% were achieved with the ILs 
[C4mim][TOS], [C4mim][CH3CO2], [C4mim]Cl, [C2mim]Cl, [C4mim]Cl, [C6mim]Cl and [C12mim]Cl. 
However, the obtained YIgG were lower than 40%. Otherwise, it was not possible to obtain values 
of 100% of EEIgG% with [C4mim]Br,[C4mim][N(CN)2], [C8mim]Cl
 and [C10mim]Cl. Nevertheless, 
remarkable results were achieved for YIgG (reaching a value of 81 % with the IL [C10mim]Cl). 
The results obtained reveal a high affinity of IgG for the polymer-rich phase; although, the 
complete extraction of IgG was never attained in a single-step in systems where no ILs are added. 
After the addition of 5 wt% of adequate ILs, extraction efficiencies of 100% of IgG were obtained, 
as well as, remarkable higher yields. From this work, it is clear that low amounts of ILs in the 
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formulation of ABS are enough to trigger complete extractions of target compounds in a single-
step. Thus, ABS composed of PEG, biodegradable organic salts and ILs (as adjuvants), can be 
envisaged as an alternative and more efficient method for the purification of biopharmaceuticals. 
 
4.2. Future work  
More ILs can be tested, in order to obtain higher YIgG% and EEIgG%, and then apply the 
improved systems to purify IgG from rabbit serum. After the purification of IgG, its recuperation 
from the PEG-rich phase should be addressed, as well as the recycling nature of the ABS used. 
Additional investigations regarding the effects of the phase-forming components through the 
protein stability and activity are also required.  
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Figure A.1 depicts the calibration curve (absorbance vs. concentration of total amount of 
protein). The calibration curve was made with rabbit IgG. 
 
 
Figure A. 1: Calibration curve for total amount of protein at λ = 280 nm.  
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The experimental weight fraction data for the phase diagrams of the systems composed of 
PEG + C6H5K3O7/C6H8O7 + H2O at pH≈7 are presented in Table B. 1 to Table B. 4. 
 
Table B. 1: Experimental weight fraction data for the system composed of PEG (1) + C6H5K3O7/C6H8O7 (2) + 
H2O (3) at 25 ⁰C and at atmospheric pressure. 
PEG 400 
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
17.6667 0.1208 1.0534 1.0162 0.5310 1.4661 
10.2530 0.1774 1.0237 1.0374 0.5184 1.4845 
5.9874 0.2684 0.9930 1.0568 0.5110 1.4868 
3.7506 0.3644 0.9370 1.1047 0.4969 1.5076 
2.9612 0.4313 0.9028 1.1277 0.4854 1.5174 
2.7227 0.4547 0.8759 1.1521 0.4719 1.5424 
2.4975 0.4891 0.8329 1.1895 0.4527 1.5662 
2.2364 0.5405 0.8172 1.1940 0.4132 1.6276 
2.1893 0.5457 0.7986 1.2099 0.3927 1.6530 
2.1194 0.5648 0.7877 1.2150 0.3657 1.6916 
2.0110 0.5975 0.7761 1.2240 0.3497 1.7120 
1.8958 0.6356 0.7696 1.2299 0.3416 1.7185 
1.8250 0.6473 0.7485 1.2454 0.3078 1.7760 
1.7728 0.6671 0.7324 1.2605 0.2841 1.8076 
1.7073 0.6871 0.7221 1.2670 0.1526 2.8601 
1.5861 0.7519 0.7021 1.2858 0.1897 1.9307 
1.4683 0.7879 0.6973 1.2877 0.3059 1.6282 
1.3953 0.8211 0.6906 1.2950 0.7904 1.0007 
1.3523 0.8397 0.6636 1.3195   
1.3358 0.8470 0.6554 1.3273   
1.2931 0.8659 0.6446 1.3380   
1.2756 0.8792 0.6368 1.3435   
1.2198 0.9177 0.6206 1.3675   
1.2061 0.9251 0.6122 1.3721   
1.1685 0.9480 0.5886 1.3928   
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Table B. 2: Experimental weight fraction data for the system composed of PEG (1) + C6H5K3O7/C6H8O7 (2) + 
H2O (3) at 25 ⁰C and at atmospheric pressure. 
PEG 600 
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
7.0842 0.0504 0.5065 0.7261 0.2511 1.0857 0.1570 1.2830 
3.6416 0.1005 0.4980 0.7351 0.2462 1.0968 0.1517 1.2921 
3.2769 0.1191 0.4896 0.7398 0.2438 1.1005 0.1456 1.3244 
1.6936 0.2361 0.4769 0.7605 0.2409 1.1047 0.1393 1.3347 
1.5467 0.2667 0.4640 0.7795 0.2391 1.1092 0.1364 1.3442 
1.4595 0.2727 0.4526 0.7877 0.2356 1.1148 0.1303 1.3504 
1.3641 0.2941 0.4394 0.8035 0.2323 1.1214 0.1250 1.3820 
1.2798 0.3052 0.4272 0.8201 0.2288 1.1278 0.1218 1.3859 
1.2184 0.3214 0.4165 0.8278 0.2249 1.1379 0.1188 1.3951 
1.1758 0.3383 0.4076 0.8436 0.2215 1.1431 0.1099 1.4279 
1.1393 0.3468 0.4023 0.8455 0.2171 1.1563 0.0963 1.4767 
1.0986 0.3628 0.3983 0.8518 0.2124 1.1644 0.1450 1.8285 
1.0668 0.3778 0.3936 0.8569 0.2087 1.1707 0.2073 1.6047 
1.0319 0.3921 0.3894 0.8612 0.2061 1.1777 0.2786 1.4788 
0.9945 0.3997 0.3836 0.8700 0.2034 1.1850 0.3238 1.3873 
0.9615 0.4122 0.3728 0.8831 0.2012 1.1862 0.3769 1.3320 
0.9423 0.4193 0.3656 0.8930 0.1982 1.1926 0.3988 1.2840 
0.9232 0.4266 0.3595 0.902 0.1952 1.1980 0.4856 1.2068 
0.8989 0.4389 0.3550 0.9078 0.1915 1.2088 0.5353 1.1413 
0.8625 0.4542 0.3515 0.9128 0.1884 1.2111 0.5673 1.1112 
0.8301 0.4768 0.3465 0.9226 0.1842 1.2228   
0.8010 0.4855 0.3426 0.9252 0.1810 1.2280   
0.7804 0.5001 0.3386 0.9311 0.1773 1.2384   
0.7644 0.5113 0.3344 0.9374 0.1720 1.2518   
0.7546 0.5151 0.3313 0.9411 0.1696 1.2538   
0.7309 0.5270 0.3274 0.9476 0.1654 1.2683   
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Table B. 3: Experimental weight fraction data for the system composed of PEG (1) + C6H5K3O7/C6H8O7 (2) + 
H2O (3) at 25 ⁰C and at atmospheric pressure. 
PEG 1000 PEG 2000 PEG 4000 
100 w1 100 w2 100 w1 100 w2 101 w1 101 w2 
0.9761 0.3060 0.2650 0.2429 0.1034 0.2536 
0.8536 0.3474 0.2562 0.2528 0.0902 0.2830 
0.7166 0.3576 0.2470 0.2631 0.0798 0.3113 
0.6533 0.3794 0.2388 0.2711 0.0694 0.3386 
0.6049 0.3948 0.2316 0.2818 0.0503 0.3996 
0.5622 0.4253 0.2218 0.2898 0.0436 0.4386 
0.530 0.4358 0.1624 0.3737 0.0390 0.4690 
0.0542 1.2678 0.1593 0.3782 0.0375 0.4752 
0.0666 1.1863 0.1548 0.3821 0.0350 0.4969 
0.0798 1.1314 0.1182 0.4583 0.0340 0.5059 
0.0885 1.1064 0.1162 0.4625 0.0331 0.5082 
0.1016 1.0688 0.1145 0.4681 0.0197 0.6183 
0.1103 1.0384 0.1106 0.4821 0.0225 0.5952 
0.1175 1.0149 0.1052 0.4976 0.0244 0.5789 
0.1287 0.9863 0.0259 0.8948 0.0264 0.5623 
0.1352 0.9708 0.0259 0.8948 0.0324 0.5245 
0.1401 0.9574 0.0366 0.7975 0.0344 0.5059 
0.1431 0.9479 0.0401 0.7755 0.0364 0.4904 
  
0.0712 0.6352 
  
  
0.0932 0.5546 
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Table B. 4: Experimental weight fraction data for the system composed of PEG (1) + C6H5K3O7/C6H8O7 (2) + 
H2O (3) at 25 ⁰C and at atmospheric pressure. 
 
PEG 6000 PEG 8000 
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
0.0691 0.2680 0.0113 0.5950 0.0070 0.6646 0.0054 0.6103 0.0065 0.5743 
0.0348 0.3721 0.0111 0.6051 0.0067 0.6667 0.0065 0.5848 0.0072 0.5657 
0.0297 0.3984 0.0108 0.6100 0.0066 0.6628 0.0083 0.5526 0.0078 0.5550 
0.0250 0.4360 0.0105 0.6131 0.0064 0.6721 0.0098 0.5293 0.0084 0.5424 
0.0245 0.4402 0.0103 0.6081 0.0063 0.6731 0.0123 0.4911   
0.0197 0.4931 0.0102 0.6210 0.0062 0.6765 0.0148 0.4558   
0.0186 0.4972 0.0100 0.6155 0.0060 0.6789 0.0169 0.4287   
0.0182 0.5072 0.0098 0.6219   0.0057 2.8291   
0.0178 0.5113 0.0096 0.6272   0.0029 0.6626   
0.0173 0.5137 0.0094 0.6216   0.0036 0.6423   
0.0170 0.5165 0.0093 0.6243   0.0044 0.6247   
0.0167 0.5228 0.0091 0.6281   0.0051 0.6056   
0.0163 0.5233 0.0090 0.6270   0.0058 0.5891   
0.0161 0.5288 0.0089 0.6337   0.0065 0.5743   
0.0158 0.5330 0.0087 0.6394   0.0072 0.5657   
0.0154 0.5460 0.0086 0.6329   0.0078 0.5550   
0.0149 0.5505 0.0085 0.6407   0.0084 0.5424   
0.0146 0.5443 0.0083 0.6478   0.0232 0.3923   
0.0143 0.5583 0.0080 0.6423   0.0225 0.3970   
0.0139 0.5560 0.0079 0.6472   0.0057 2.8291   
0.0135 0.5694 0.0078 0.6513   0.0029 0.6626   
0.0130 0.5783 0.0076 0.6474   0.0036 0.6423   
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The experimental weight fraction data for the phase diagrams of the systems composed of 
PEG 400 + C6H5K3O7/C6H8O7 at different pH values + H2O are presented in Table B. 5 to Table B. 6. 
 
Table B. 5: Experimental weight fraction data for the systems composed of PEG 400 (1) + C6H5K3O7/C6H8O7 (2) 
+ H2O (3) at different pH values, at 25 ⁰C and atmospheric pressure. 
pH≈5 pH≈6 
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
97.6785 1.1474 83.1460 3.1973 26.1275 24.0347 
59.4245 10.5023 80.2857 3.9381 27.1130 23.3590 
54.8208 12.4952 74.0831 5.5981 27.8631 22.8964 
51.8751 13.4461 70.2003 6.3838 28.4717 22.4577 
43.1889 17.5656 67.5146 7.2412 29.0311 21.9991 
37.4680 20.1883 62.7472 8.2251 30.0644 21.4199 
29.6068 25.8032 60.1183 8.7867 30.7338 20.9344 
79.5788 4.5648 52.5302 11.5347 31.3464 20.2928 
75.1961 5.3173 42.9395 14.2884 32.5943 19.6152 
42.5024 17.6484 41.0086 15.0556 33.0527 19.2490 
37.5837 20.4752 39.3498 15.8188 33.9441 18.5133 
43.8210 17.3961 37.4010 16.9016 34.8239 18.0871 
38.0120 20.3881 8.3076 39.0424 35.6767 17.4873 
35.6522 21.0005 10.2215 36.9386   
31.98544 24.1809 11.0343 36.0117   
32.41776 23.6163 11.8581 35.3441   
33.04591 23.1484 12.6053 34.5915   
34.39002 22.2523 13.2279 33.8544   
35.73221 21.4667 15.3038 32.1482   
39.17455 19.1808 16.7716 31.1742   
24.76493 30.11694 17.2677 30.5668   
21.7746 32.0034 18.5333 29.6867   
20.3919 34.5012 19.1007 29.1624   
25.2329 28.9867 20.3021 28.3650   
16.3097 37.7884 21.5244 27.5649   
18.7841 35.7096 21.9908 27.1238   
17.5897 36.5537 22.9232 26.4286   
12.0404 41.5647 23.9513 25.7182   
  24.2902 25.2971   
  25.1437 24.6179   
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Table B. 6: Experimental weight fraction data for the systems composed of PEG 400 (1) + C6H5K3O7/C6H8O7 (2) 
+ H2O (3) at different pH values, at 25 ⁰C and atmospheric pressure. 
pH≈9 pH≈8 
100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 100 w1 100 w2 
98.7614 0.6114 19.6993 25.3901 97.9816 1.0131 6.0589 36.1366 
68.2447 3.1421 18.8710 26.0018 72.0986 2.9437 7.0630 35.2505 
65.9899 3.8872 18.3604 26.2245 65.5590 4.2215 9.0933 33.1761 
63.3480 4.3566 17.8041 26.6026 61.8489 5.2348 9.9558 32.3053 
61.1248 5.2798 17.4656 26.8562 58.1287 6.1471 10.9065 31.6091 
57.1765 6.8965 16.6855 27.3949 53.9687 7.3423 11.7741 30.9423 
54.4698 7.5474 16.3474 27.6280 51.7503 8.0110 12.5534 30.3797 
53.3535 7.8675 16.1222 27.7605 46.5439 10.5737 13.3199 29.8972 
50.7736 8.8696 15.7539 28.0582 44.9058 11.0891 13.9490 29.2169 
49.7684 9.1850 15.5798 28.1564 43.1049 12.0416 15.2438 28.3406 
46.7201 10.6741 15.2734 28.3902 41.6065 12.7035 15.8502 27.7407 
44.9089 11.6286 15.0137 28.5631 40.3051 13.2035 17.2340 26.9222 
43.2403 12.1418 14.8760 28.5919 38.3276 14.2975 17.8247 26.4605 
42.1962 12.5506 14.5414 28.8819 36.8786 14.7359 18.8281 25.7318 
40.4663 13.1536 2.4456 48.1525 33.2908 16.7460   
39.4923 13.5933 3.7524 44.0195 32.3498 17.2076   
38.1205 14.3601 4.6473 40.0228 31.8512 17.4923   
37.4959 14.5110 5.5669 38.1322 31.2476 17.8160   
35.8609 15.6126 6.6937 36.3331 30.1857 18.6230   
34.5416 16.0606 7.4991 34.8308 29.5314 18.9394   
33.8126 16.3824 8.9759 33.0886 28.9074 19.1716   
32.9396 16.9120 10.7990 31.8381 28.0889 19.6419   
32.0742 17.4605 11.5234 31.1063 27.5907 19.9676   
30.7456 18.0696 12.3085 30.3982 26.8083 20.5204   
29.1959 19.0198 13.9001 29.3979 26.3774 20.8019   
27.6533 20.0223 14.9116 28.6416 25.9860 21.0619   
26.5636 20.6568 16.4486 27.7227 25.2994 21.4896   
24.8188 21.8903 17.0294 27.1178 24.8228 21.8130   
24.2601 22.2001 19.6993 25.3901 24.4753 22.0550   
23.7156 22.5333 18.8710 26.0018 23.9810 22.3626   
22.8205 23.2478 18.3604 26.2245 23.5928 22.6428   
22.4224 23.4550 17.8041 26.6026 23.2114 22.9108   
21.8741 23.8240 17.4656 26.8562 22.8346 23.1516   
98.7614 0.6114 16.6855 27.3949 22.3768 23.4472   
68.2447 3.1421   21.8416 23.7413   
65.9899 3.8872   21.4612 24.0039   
63.3480 4.3566   21.0831 24.2745   
61.1248 5.2798   20.7018 24.5273   
57.1765 6.8965   20.2810 24.8188   
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Additional data for the ABS composed of PEG + C6H5K3O7/C6H8O7 + H2O at pH ≈ 7 are shown in 
Figure C.1 and Table C. 1. 
 
Figure C. 1: Evaluation of the molecular weight of PEG in ABS composed of  
PEG + C6H5K3O7/C6H8O7 + H2O: PEG 400 (); PEG 600 (×); PEG 1000 (); PEG 2000 (); PEG 4000 (); PEG 
6000 () PEG 8000 (). 
 
 
Figure C. 2: Phase diagrams for PEG–potassium citrate systems with different PEG molecular weights at  
30 ⁰C (107). 
 
 
  
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
[P
EG
] /
 (m
ol
. k
g-
1 )
[Citrate buffer] / (wt %)
0.00
0.04
0.08
0.12
0.16
0.30 0.50 0.70 0.90
Extraction and purification of IgG with ABS 
 
86 
 
 
Table C. 1: Critical points of the investigated systems PEG (400, 600, 1000, 2000, 4000, 6000 and 8000) + 
C6H5K3O7/C6H8O7 at pH ≈ 7 + H2O. 
Critical Points (wt %) 
MW PEG C6H5K3O7/C6H8O7 PEG 
400 23.86 22.98 
600 22.96 15.29 
1000 18.09 19.22 
2000 15.53 12.74 
4000 12.23 13.94 
6000 12.00 12.42 
8000 12.48 9.85 
 
Additional data for the ABS composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O at different pH 
values are shown in Figure C.3 and Table C.2. 
 
  
Figure C. 3: Evaluation of the molecular weight of PEG in ABS composed of  PEG 400 + C6H5K3O7/C6H8O7 + 
water at 25 ⁰C and atmospheric pressure at different pH: pH 5(), pH 6 (), pH 7 (), pH 8 ()and pH 9 
(). 
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Table C. 2: Critical points of the investigated systems (PEG 400+ C6H5K3O7/C6H8O7 + H2O) at different pH 
values. 
Critical Points / (wt %) 
pH PEG 400 C6H5K3O7/C6H8O7 
5 13.87 39.29 
6 20.98 27.51 
7 22.24 24.35 
8 24.23 22.11 
9 26.40 20.80 
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Experimental data for extraction efficiency (EEIgG %) and partition coefficient of IgG (K) and 
extraction yield in the top phase (YIgG %), for systems composed of PEG + C6H5K3O7/C6H8O7 at pH 
≈7 + H2O at different times of extraction and rest from Table D.1 to Table D.2. 
 
Table D. 1: Results of partition coefficient, extraction efficiency and extraction yield of rabbit IgG, with the 
associated standard deviation, using systems formed by PEG 400 and 8000. Times of equilibrium ranging 
from 10 to 120 min, before 10 min of centrifugation at 1000 rpm, and 300 and 720 min of equilibrium time 
without centrifugation. 
 
PEG Time (min) KIgG 
Standard  
deviation 
EEIgG % 
Standard  
deviation 
YIgG % 
Standard  
deviation 
400 
10 11.44 0.83 91.93 0.56 41.54 4.44 
30 7.20 0.15 87.80 0.22 40.32 2.17 
60 17.26 5.92 93.88 1.98 39.41 3.91 
120 22.72 4.34 95.61 0.93 40.32 2.87 
300 7.55 1.95 87.66 2.82 42.18 0.80 
720 12.06 1.79 92.21 0.98 46.21 2.71 
8000 
10 1.45 0.15 59.11 2.43 34.08 2.62 
30 0.32 0.13 23.23 7.65 12.24 6.88 
60 1.03 0.08 50.74 1.97 23.71 2.06 
120 0.41 0.15 38.17 7.43 7.15 5.47 
300 1.31 0.08 56.61 1.58 41.79 4.94 
720 2.10 0.69 66.11 7.54 39.95 4.35 
 
Table D. 2: : Results of partition coefficient, extraction efficiency and extraction yield of rabbit IgG, with the 
associated standard deviation, using systems formed by PEG 400, 2000 and 8000. Times of equilibrium 
ranging from 10 to 120 min, before 10 min of centrifugation at 1000 rpm, and 300 and 720 min of 
equilibrium time. 
PEG Time (min) KIgG 
Standard  
deviation 
EEIgG % 
Standard  
deviation 
YIgG % 
Standard  
deviation 
400 
60  17.26 5.92 93.88 1.98 37.54 3.91 
120  22.72 4.34 95.61 0.93 40.32 2.87 
180  18.86 7.75 94.17 2.13 72.23 3.25 
2000 
60  3.01 1.20 72.58 8.24 43.58 6.88 
120  2.58 0.50 71.58 3.66 59.59 4.09 
180  2.04 0.31 66.77 3.43 21.17 0.61 
8000 
60  1.03 0.08 50.74 1.97 23.71 2.06 
120  0.41 0.15 38.17 7.43 7.15 5.47 
180  0.73 0.06 42.17 1.89 21.80 0.53 
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Experimental data for the extraction efficiency (EEIgG %), partition coefficient (K) and 
extraction yield (YIgG %) of rabbit IgG using the systems composed of C6H5K3O7/C6H8O7 + H2O + 
PEGs of different molecular weights at pH ≈7 are presented in Table D.3. 
 
Table D. 3: : Results of partition coefficient, extraction efficiency and extraction yield of rabbit IgG, with the 
associated standard deviation, using systems formed by PEG 400, 600, 1000, 2000, 4000, 6000 and 8000. 
Times of equilibrium ranging from 10 to 120 min, before 10 min of centrifugation at 1000 rpm. 
PEG Time (min) KIgG 
Standard  
deviation 
EEIgG % 
Standard  
deviation 
YIgG % 
Standard  
deviation 
400 
120  
1000 rpm 
22.72 4.34 95.61 0.93 40.32 2.87 
600 14.10 1.19 97.79 3.12 44.41 0.74 
1000 8.69 1.27 89.50 1.37 43.82 7.69 
2000 3.01 1.20 54.49 9.86 43.58 6.88 
4000 1.93 0.46 64.95 5.95 32.96 7.05 
6000 1.99 0.26 82.55 9.07 41.00 3.52 
8000 0.41 0.15 38.17 7.43 7.05 5.47 
 
The experimental data for extraction efficiency (EEIgG %), partition coefficient (K), and yield 
(YIgG %) of rabbit IgG in the systems composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O at different pH 
values are shown in Table D.4. 
 
Table D. 4: Extraction efficiency (EEIgG %), partition coefficient (K), and yield (YIgG %) of rabbit IgG in the 
systems composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O at different pH values. 
PEG pH 
KIgG 
Standard  
deviation 
EEIgG % 
Standard  
deviation 
YIgG % 
Standard  
deviation 
400 
6 30.22 2.05 96.68 3.35 45.65 3.33 
7 22.72 4.34 95.61 0.93 40.32 2.87 
8 36.04 1.42 97.30 1.69 49.40 1.69 
9 41.64 5.54 97.07 2.56 43.26 2.28 
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The experimental data for extraction efficiency (EEIgG%), partition coefficient (K) and 
extraction yield (YIgG %) of rabbit IgG in the systems composed of PEG 400 + C6H5K3O7/C6H8O7 at pH 
≈7 + H2O and 5% of different ILs as adjuvants are shown in Table D.5 and Table D.6. 
 
Table D. 5: Extraction efficiency (EEIgG %), partition coefficient (K), and yield (YIgG %) of rabbit IgG in the 
systems composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O + 5% of [C4mim]-based ILs
 
(IL anions: Cl
-
, [Tos]
-
, Br
-
, 
[CH3CO2]
-
, [N(CN)2]
-
) at pH ≈ 7.
 
ILs 
KIgG 
Standard  
deviation 
EEIgG % 
Standard  
deviation 
YIgG % 
Standard  
deviation 
No IL 22.72 4.34 95.61 0.93 40.32 2.87 
[C4mim]Cl 60.00 --- 100.00 --- 36.89 9.31 
[C4mim][TOS] 60.00 --- 100.00 --- 36.83 6.73 
[C4mim]Br 60.00 --- 89.73 10.27 55.06 10.01 
[C4mim]Ac 60.00 --- 100.00 --- 26.81 5.90 
[C4mim][N(CN)2] 60.00 --- 93.13 8.00 31.13 1.41 
 
 
Table D. 6: Extraction efficiency (EEIgG %), partition coefficient (K), and yield (YIgG %) of rabbit IgG in the 
systems composed of PEG 400 + C6H5K3O7/C6H8O7 + H2O + 5% of 5% of [Cnmim]Cl ILs (with n= 2, 4, 6, 8, 10, 
12, 14) at pH ≈ 7.
 
[Cnmim]Cl KIgG 
Standard  
deviation 
EEIgG % 
Standard  
deviation 
YIgG % 
Standard  
deviation 
              No IL 22.72 4.34 95.61 0.93 40.32 2.87 
[C2mim]Cl 60.00 --- 100.00 --- 25.44 9.85 
[C4mim]Cl 60.00 --- 100.00 --- 36.89 9.31 
[C6mim]Cl 60.00 --- 100.00 --- 30.37 3.42 
[C8mim]Cl 4.79 --- 82.70 0.82 72.35 5.87 
[C10mim]Cl 52.96 --- 94.61 3.70 81.24 11.79 
[C12mim]Cl 60.00 --- 100.00 --- 30.01 5.50 
[C14mim]Cl 60.00 --- 97.63 3.36 41.23 5.17 
 
